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The potential mutagenicity and clastogenicity (ability to cause chromosomal damage) of five South 
African traditional medicinal plants: Acokanthera oppositifolia (Lam.); Pelargonium sp. cf. inquinans 
( L.) L’ Herit; Pteridium aquilinum subsp aquilinum; Rumex lanceolatus Thunb. and Zantedeschia 
aethiopica (L.) Sg, were investigated using two in vitro tests in both a bacterial and a mammalian 
cell system. The Salmonella reverse mutation assay and chromosomal aberration test, two 
frequently used and accepted pharmacological bioassays, were selected for the investigation. The 
rat liver extract (S9), containing CYP P450 and other liver enzymes, was added to the in vitro cell 
system to detect pro-mutagens that require metabolic activation in order to exert mutagenicity or 
clastogenicity – directly acting mutagens do not require metabolic activation.  
 
A significant mutagenic potential (p≤0.01) was evident with the Salmonella reverse mutation assay 
for three of the aqueous plant extracts: (i) R. lanceolatus (in strains TA97a, TA98, TA100 and 
TA102) with and without metabolic activation (S9), (ii) P. aquilinum in TA100 with S9 and in TA102 
without S9 and (iii) Pelargonium (in TA102) without S9. Furthermore, R. lanceolatus and P. 
aquilinum were clastogenic in the chromosomal aberration test but this effect was reduced with S9. 
Z. aethiopica demonstrated clastogenicity, which was reduced with S9, but the extract was not 
mutagenic. 
 
Since the chromosomal aberration test is dependent on cells entering the cell cycle (Go-G1, S and 
G2-M) and chromosome visibility with light microscopy only occurs at metaphase, the clastogenicity 
of A. oppositifolia and Pelargonium could not be detected because these extracts inhibited mitosis 
(M).  A DNA analysis of cultures treated with A. oppositifolia and Pelargonium by Flow Activated 
Cell Sorting (FACS) indicated a blockage in the Go/G1 phase of the cell cycle. 
 
The in vitro mutagenicity and clastogenicity tests served as a preliminary investigation into the 
safety of five traditional plants. In addition to mutagenicity testing, it is suggested that further 
scientific evaluation, validation, standardisation and regulation of South African traditional medicine 
























1.1 Background  
A major part of the population of both urban and rural communities in South Africa is reliant on 
traditional medicine as opposed to westernised medicine (Van Wyk et al., 1997 and Eldeen et al., 
2005). This is because herbal medicines are an important part of the culture and tradition of African 
people and are generally more accessible and affordable. However, many investigations have 
shown that plants used as food or in traditional medicine have mutagenic and carcinogenic effects 
in in vitro and in vivo assays as well as in humans (Stickel and Seitz, 2000, Zhang et al., 2004, 
Zhou et al., 2004, Meinl et al., 2006 and Reid et al., 2006).  
 
The Salmonella reverse mutation assay (Maron and Ames, 1983) is widely used in determining 
possible gene mutations caused by extracts (Reid et al., 2006). A chemical that is mutagenic in 
Salmonella is presumed to be a rodent carcinogen (and potential human carcinogen) (Zeiger, 
2001). The chromosome aberration test is commonly used as a biomarker for the early effects of 
genotoxic carcinogens.  
 
Plant extracts are prepared from the aerial parts of the plant or roots and the most commonly used 
solvents are water, dichloromethane and methanol. Such extracts contain only the soluble fractions 
of the plant material (usually about 20% of the total weight) and the non-soluble (fibrous) residues 
(about 80%) are discarded (Gurib-Fakim, 2006). A plant extract that produces a mutagenic or 
clastogenic response is a result of one or more phytochemicals in the extract.  
 
1.2 Phytochemicals 
Phytochemicals that are produced from primary metabolism are associated with the fundamental 
life processes common to all plants, such as photosynthesis, the pentose cycle, glycolysis and the 
citric acid cycle. The secondary plant metabolites contribute to the taxonomic and biochemical 
differentiation, and diversity within the plant kingdom. Furthermore, secondary plant metabolites 
evolved as chemical defences to repel, stun, poison or kill other species or predators; therefore it 
would be naive to think that every plant extract is necessarily safe for human consumption. The 
beneficial and adverse effects of phytochemicals are discussed in the following sections. 
 
1.2.1 Beneficial effects 
Traditional plants have been used for dietary and medicinal purposes for centuries and continue to 
be popular. There are many examples of the beneficial effects of traditional plants such as their 
chemopreventative activity when herbal constituents form reactive intermediates capable of 
irreversibly inhibiting various cytochrome P450s and their antibacterial and anti-inflammatory 














other beneficial effects (Table 1). The pharmacological screening of medicinal plants is very 
important because it provides a scientific basis for the continued use of plants and could be 
potential sources of new, effective and safe drugs (Eldeen et al., 2005).  
 
Table 1: Plant compounds and extracts with beneficial medicinal effects 
Chemical 
compound/extract 
Botanical source Biological activity Reference 
Scopolamine 
(alkaloid) 
Datura stramonium Anti-muscarinic agent, smooth 
muscle relaxant and anti-
nauseant 







Resperine Rauwolfia serpentina Used for the treatment of high 
blood pressure 
Craig, 1999 
Taxol Taxus brevifolia A chemotherapeutic agent Craig, 1999 
Atropine (alkaloid) Datura stramonium Reduces rigidity in 
parkinsonism and is used as 
an antidote to poisoning with 
parasympathomimetic agents 












Narcotic analgesic (pain relief) 







Anti-cancer drugs that interfere 
with the turbulines of the 
mitotic and meiotic spindle that 







In vitro antibacterial, antiviral, 
and immunomodulatory 
properties in several studies. 
Efficacy has been proved in 
numerous clinical trials. 
Therapeutic effect in acute 
bronchitis, tonsillopharyngitis, 
sinusitis and symptoms of the 
common cold. 
Bereznoy et 
al., 2003,  
Beil and 
Kilian, 2007,  
Agbabiaka et 







Aspalathus linearis,  
Cyclopia intermedia 
(i) In vitro antimutagenicity,  










Despite the beneficial effects of plant compounds and extracts many adverse effects continue to 
be reported (Stickel and Seitz, 2000, Zhang et al., 2004, Zhou et al., 2004, Meinl et al., 2006 and 
















1.2.2 Adverse effects 
Although a few plant extracts and numerous bioactive compounds that have been isolated from 
plants have medicinal value, the ingestion of some plants and/or their extracts has been linked to 
acute (short-term) or chronic (long-term) effects.  
 
1.2.2.1 Acute effects  
The symptoms of acute effects are toxicity (mainly acute hepato-toxicity), poisoning and acute 
veno-occlusive liver disease (VOD), which is a non-thrombotic obliteration of small hepatic veins 
leading to cirrhosis and, eventually, liver failure, which is diagnosed from a liver biopsy and 
histopathology. Acute effects usually result from the ingestion of large quantities of plant material 
over a short period:  
(i) Datura stramonium, traditionally used for the treatment of gout, boils, wounds and asthma 
and to reduce pain, is extremely toxic because of two main alkaloids, namely atropine and 
scopolamine, which have been linked to deaths and poisoning for centuries (van Wyk et al., 
1997, Miraldi et al., 2001, Steenkamp et al., 2004 and Friedman, 2004). However, both 
atropine and scopolamine have pharmaceutical significance (refer to Table 1).  
(ii) VOD is related to the ingestion of plants containing various pyrrolizidine alkaloids, such as 
Symphytum officinale, commonly referred to as comfrey (Stickel and Seitz, 2000). In South 
Africa many VOD cases have been reported and genera known to contain pyrrolizidine 
alkaloids are Senecio and Crotalaria (Steenkamp et al., 2000).  
(iii) The high oxalic acid content of Rumex sp (leaves and root) used in traditional medicine has 
been implicated in oxalic intoxication mainly in children. However, when oxalic acid is used 
medicinally as a 5% solution in 5% malonic acid it is beneficial as a haemostatic agent (The 
review of natural products, 2002, and van Wyk and Wink, 2004).  
 
1.2.2.2 Chronic effects 
A chronic effect results from the ingestion of small quantities of plant material over a long period. 
This can cause organ damage such as in the liver and kidneys. Carcinogenesis can also result 
from the ingestion of plant material. 
(i) A case-control study on the ‘usual consumption’ of the plant Solanum nigrum in the 
Transkei has been associated with an irritating effect on the oesophageal mucosal lining 
(Sammon, 1992) and oesophageal cancer (IARC Scientific Publication 2003, No.153).   
(ii) The use of Comfrey leaves (Symphytum officinale) has been recognised as a substantial 
health hazard, with hepatic toxicity in humans and carcinogenic potential in rodents 
resulting from its pyrrolizidine alkaloids: lasiocarpine and symphytine, and their related N-
oxides (Stickel and Seitz, 2000). The South African traditional medicine, Senecio latifolius, 
which is known to contain toxic pyrrolizidine alkaloids, is a potential teratogen and 













(Steenkamp et al., 2001). Pyrrolizidine alkaloids are ubiquitous in the plant kingdom but to 
date only the retronecine, heliotridine and otonecine types exhibit high toxicity and 
tumourigenicity in experimental animals (the metabolism of these three types are the most 
studied) (Fu et al., 2004). 
(iii) The use of herbal preparations of Aristocholia sp led to progressive nephropathy and 
urothelial cancer in humans owing to the formation of DNA adducts in human target tissue 
(Zhang et al., 2004; Zhou et al., 2004 and Meinl et al., 2006).  
(iv) The use of Pteridium aquilinum has been related to mutagenicity and carcinogenicity in in 
vitro, in vivo and epidemiological studies owing to its bioactive compound, ptaquiloside, and 
its metabolic intermediate, pteridienone, elaborated in section 1.7.1. Metabolic activation 
may influence the mutagenic potential of a phytochemical, as in the case of pteridienone 
which was found to have more pronounced activity over ptaquiloside (Matsuoka et al., 
1989). Therefore, mutagenicity tests are generally performed with and without metabolic 
activation by rat liver microsomes (S9). 
 
1.3 Metabolism of chemical carcinogens 
The liver is the major detoxification centre in the body where chemicals undergo biotransformation 
to a more “excretable” (i.e. water-soluble) form. Cytochrome P450 and liver enzymes 
(transferases) have critical roles in the metabolism of steroids and eicosanoids, and other 
biosynthetic processes, and are involved in activation of pro-carcinogens as the first step to their 
removal. Pro-carcinogens or pro-mutagens are not carcinogenic/mutagenic on their own but 
require metabolic activation to intermediates in order to exert their effect. Mutagenicity tests 
incorporate CYP P450 in the form of rat liver homogenate S9 for the detection of pro-mutagens in 
plant extracts. The metabolism of drugs or xenobiotics in the liver occurs in two steps known as 
Phase I and Phase II reactions. 
 
Phase I reactions: Cytochrome P450 enzymes, 1A1, 1A2, 1B1, 2A6, 2E1 and 3A4, play a 
prominent role in the metabolism of carcinogens, both in bioactivation and detoxification 
(Guengerich and Shimada, 1991 and Guengerich, 2001). Carcinogens have reactive electrophilic 
groups that can bind to DNA directly and cause mutations and cancer. However, pro-carcinogens 
are enzymatically activated by CYP P450 into reactive electrophiles (e.g. ptaquiloside to 
pteridienone) that can bind to DNA and also cause mutations and cancer. It is therefore imperative 
that in vitro mutagenicity tests incorporate CYP P450 or liver microsomes for the detection of pro-
mutagens that are potential pro-carcinogens (confirmed by a two-year in-vivo study). Most Phase II 
enzymes deactivate pro-carcinogens. Plant compounds may initiate the carcinogenic process 
















1.4 Plant extract-induced DNA mutations and genotoxicities 
Plant extracts or compounds may cause DNA damage through point mutations, chromosomal 
alterations and other genotoxicities (e.g. DNA adducts, DNA crosslinking). Point mutations involve 
one or more nucleotides (e.g. frameshift mutations and base pair substitutions) while chromosomal 
alterations encompass several nucleotides.  
 
1.4.1 Point mutations 
A variety of traditional plant extracts and compounds produce point mutations: 
(i) Aristolochic acid, the active compound from Aristolochia species, is mutagenic with the 
Salmonella reverse mutation assay in strains TA98 and TA100, indicative of frameshift and 
base-pair substitution mutations respectively, and in the mouse lymphoma assay (Zhang et 
al., 2004). 
(ii) Two extraction procedures were used in a sequential manner to extract polar (methanol-
water soluble) and apolar (dichloromethane) compounds from Cyrtanthus falcatus and 
Cyrtanthus suaveolens (Family: Amaryllidaceae), which are commonly used in SA 
traditional medicine (Elgorashi and van Staden, 2004). The dichloromethane (DCM) 
extracts of the leaves and roots of C. falcatus, and the bulbs/roots and leaves of C. 
suaveolens induced mutation in the Salmonella reverse mutation assay in strain TA98, 
while none of the 90% methanol extracts of the different plant parts of the two species 
induced mutagenicity in TA98. Since the DCM extracts of C. falcatus and C. suaveolens 
induced frameshift mutations detected by TA98, the traditional medicine should be used 
with caution since rigorous toxicological investigations are required. 
(iii) Helichrysum simillimum, Helichrysum herbaceum and Helichrysum rugulosum, extensively 
used in SA traditional medicine in the treatment of coughs, colds, fever, infections, 
headache and menstrual pain (Van Wyk et al., 1997), showed mutagenicity in the 
Salmonella reverse mutation assay in strains TA98 and TA100 with the 90% methanol 
extracts, which is indicative of frameshift and base-pair substitution mutations respectively 
(Reid et al., 2006).  
 
Plant extractions using both polar and apolar solvents would add to scientific knowledge; however, 
the validation of the plant extract would be compromised because traditional healers mainly use 
water as a solvent in the preparation of plant extracts, mostly as decoctions and/or infusions. 
 
1.4.2 Chromosomal alteration   
(i) South African traditional medicinal plant extracts, Afzelia quanzensis Welw.; Bersama 
lucens (Hochst.) Szyszyl; Ocotea bullata; Siphonochilus aethiopicus and Tetradenia riparia 
(Hochst.) Codd (Lamiaceae), induced DNA damage as detected in the comet assay (Taylor 














(ii) Extracts of Antidesma venosum E. Mey. Ex Tul.; Balanities maughamii Sprague, 
Catunaregan spinosa (Thunb.) Tirveng.; Chaetacme aristata, Croton sylvaticus Hochst.; 
Diospyros whyteana (Hiern) F. White; Euclea divinorum Hiern; and Gardenia volkensii K. 
Schum caused both DNA damage and chromosomal aberrations in human white blood 
cells as detected by the comet assay and micronucleus tests respectively (Taylor et al., 
2003). The micronucleus test detects chromosome breakage and/or chromosome loss. 
(iii) The dichloromethane extracts of twigs/bark of Gardenia volkensii and Spirostachys africana 
common South African traditional medicinal plants, were found to be genotoxic in the 
micronucleus test (Verschaeve et al., 2004). 
(iv) Aristolochic acid from the Aristolochia species caused an increase in chromosomal 
aberrations in Chinese hamster ovary (CHO) cells, with and without metabolic activation by 
S9 (Zhang et al., 2004).  
 
1.4.3 Other genotoxicities 
(i) Pyrrolizidine alkaloids are naturally occurring phytochemicals that are common constituents 
of hundreds of plant species worldwide. Some pyrrolizidine alkaloids exhibit a variety of 
genotoxicities, including DNA binding, DNA cross-linking and DNA-protein cross-linking 
(Reed et al., 1988, Hincks et al., 1991 and Coulombe et al., 1999).  
(ii) Aristolochic acid, the active compound from Aristolochia species, produces DNA adducts in 
human target tissue. Aristolochic acids undergo reduction of the nitro group by hepatic 
cytochrome P450 (CYP1A/2) or peroxidases in extrahepatic tissues to reactive cyclic 
nitrenium ion that are capable of reacting with DNA and proteins, has been shown to 
activate the H-ras oncogene (Zhou et al., 2004). 
 
Several plants used in South African traditional medicine have the potential to cause long-term 
damage to genetic material in patients when administered as medicinal preparations (Fennell et 
al., 2004). The generation of DNA damage, which can arise from a direct or indirect mechanism, is 
considered an important initial event in carcinogenesis. Mutagenicity tests generally detect those 
chemicals that cause direct DNA damage. 
 
1.5 Mechanism of DNA damage 
Direct mechanisms refer to DNA damage arising from point mutations, chromosome or genome 
alteration, while indirect mechanisms refer to the interaction of chemical compounds with non-DNA 
targets leading to genotoxic effects such as lipid peroxidation and protein adducts (Kirsch-Volders 
et al., 2003). Carcinogenicity caused by Aristolochia sp is induced by direct and indirect DNA 
damaging mechanisms. The metabolic intermediate of aristolochic acid produces DNA adducts 
(direct mechanism) and protein adducts (indirect mechanism). Examples of chemical compounds 














Table 2: Plant extracts and chemical compounds shown to cause direct DNA damage 
Extract/Compound 























































































































1.6 Known plant carcinogens 
Many plant carcinogens have been identified from phytochemical and related studies; however, 
only pyrrolizidine alkaloids and aristolochic acid are discussed in this section. 
 
1.6.1 Pyrrolizidine alkaloids 
Pyrrolizidine alkaloids are categorised into retronecine (e.g. riddelliine, senecionine), heliotridine 
(e.g. lasiocarpine, heliotrine) and otonecine (e.g. clivorine) types. These are metabolised by the 













metabolising enzyme responsible for the metabolic activation by human liver microsomes. 
Metabolic pathways involving N-oxidation and hydrolysis of these pyrrolizidine alkaloid types 
produce chemical end products that are reactive toward protein or DNA to form 
dehydropyrrolizidine (DHP)-derived adducts (Fu et al., 2004). Male rats were reported to be more 
susceptible than female rats to pyrrolizidine alkaloids, with a higher mortality when riddelliine was 
administered at 1mg/kg/day, five days per week leading to the termination of the study at 72 
weeks, whereas the same study in female rats lasted for 104 weeks (Chan 2001). 
 
The reasons for the marked gender difference in rats was ascribed to: (i) the production of toxic 
metabolites of riddelliine, such as pyrrolic esters, bound pyrrole and DHP-derived DNA adducts in 
the male rat; (ii) male-specific isoenzymes CYP3A and CYP2C11 that catalyse biotransformations 
in senecionine toxicity; and (iii) the lack of CYP3A1 and CYP3A2 activities in female rats leading to 
a significantly low metabolic activation rate of clivorine, making them less susceptible to 
intoxication (Williams et al., 1989, Chan 1993, Chan et al., 1994 and Chan 2001). 
 
There are no reports on a gender difference in the susceptibility of humans to pyrrolizidine alkaloid 
intoxication; it is unlikely that such a gender difference occurs in humans because there is no 
evidence exhibiting significant variations of human CYP3A4 expression (Fu et al., 2004). However, 
the abundance of CYP3A4 in the liver varies significantly between individuals and in different 
ethnic groups, which may result in marked variations in the metabolic profile and thus different 
susceptibilities to pyrrolizidine alkaloid intoxication (Fu et al., 2004).  
 
1.6.2 Aristolochic acid 
The Aristolochia species contain the active compound aristolochic acid, an alkaloid that plays a 
major role in DNA adduct formation in human target tissues. Products containing aristolochic acid 
were withdrawn from the market in the early 1980s because it was found to be a potent carcinogen 
(Zhang et al., 2004). The cyclic nitrenium ion metabolic intermediate produced from aristolochic 
acid metabolism (Fig 1.) interacts with DNA and the use of herbal preparations containing 
Aristolochia species has led to progressive nephropathy and urothelial cancer in humans (Meinl et 
al., 2006).  
 
Only a minority of the users of Aristolochia-containing products develop nephropathy and cancer, 
suggesting differences in individual susceptibility. Human sulfotransferases (SULTS) reinforce the 
mutagenic activity of aristolochic acids through activation by SULT1A1 and SULT1B1 (Meinl et al., 
2006). A SULT1A1 inhibitor reduces the mutagenic effect of aristolochic acid in a mammalian cell 
system. SULT1A1 and SULT1B1 are expressed in the human kidney but at levels substantially 














produced in other tissues and transferred to the target organs such as the kidney (Meinl et al., 
2006). 
 
Aristolochic acid has demonstrated mutagenicity (i) in the Salmonella reverse mutation assay in 
strains TA98 and TA100 indicating frameshift and base-pair substitution mutations, (ii) in the  
mouse lymphoma assay and (iii) an increase in chromosomal aberrations in Chinese hamster 


























Fig1. Proposed bioactivation of aristolochic acids (AA). The reduction of the nitro group of AAI 
(R = H) and AAII (R = OCH3) to reactive cyclic nitrenium ions is catalysed by oxidative enzymes 
(such as hepatic microsomal CYP1A1/2, NADPH:CYP reductase, DT-diaphorase, 
cyclooxygenase-1 and other peroxidases). The cyclic nitrenium ions are capable of reacting with 
DNA and/or proteins, leading to adduct formation. The formation of DNA adducts has been found 
to decrease or increase through the addition of inhibitors or inducers of CYP1A1/2 respectively. 
DNA-aristolactam adducts [e.g. (7-deoxyadenosin-N6-yl) aristolactam I or II and (7-deoxyguanosin-
N2-yl) aristolactam I or II] have been detected in the kidney and ureter tissues of patients taking 
herbs containing AAs several months or years after cessation of the herbal consumption (Zhou et 
al., 2004). 
 
The use of simplified in vitro tests: (i) Salmonella reverse mutation assay (Ames et al., 1975 and 
Maron and Ames, 1983); (ii) mouse lymphoma mutagenicity test (Clive et al., 1987) and (iii) 
chromosomal aberration test (Galloway et al., 1994), has demonstrated that the genotoxicity of 













genotoxicity assays had been used during early product development (Zhang et al., 2004). 
Furthermore, such screening tests provide a rapid and economical way of obtaining preliminary 
genotoxicity profiles of new substances or products as an aid to decision making for further 
development. 
  
1.7 Phytochemical content of the five plants investigated 
The plants currently used in traditional medicine and investigated in the current study were 
Pteridium aquilinum subsp aquilinum, Zantedeschia aethiopica (L.), Acokanthera oppositifolia 
(Lam.), Rumex lanceolatus Thunb. and Pelargonium sp. cf. inquinans (L.) L’ Herit. 
 
1.7.1 Pteridium aquilinum  
P. aquilinum, commonly known as bracken fern, belongs to the Family: Dennstaedtiaceae. It is 
found throughout the southern and eastern part of South Africa, and is common in moist regions 
and at high altitudes, where it often forms dense stands, particularly after a fire (Van Wyk et al., 
2002). Bracken poisoning in bovine, caprine and equine livestock occurs when the plant is 
interspersed in grazing fields or is a contaminant in fodder. Young fronds and rhizomes are cooked 
and eaten by the Zulu and Tswana (Roberts, 1990). 
 
 
Fig 2. P. aquilinum is a fern with numerous firm-textured leaves, which are called fronds. Such 
fronds are generally 1 to 2 feet long and 1 to 2 feet wide. Young leaves are characteristically coiled 
in a bud (appear as hook-shaped tips) which uncurls during leaf development. Ferns are 
flowerless, seedless vascular plants that reproduce by means of spores, have roots that emanate 
from a rhizome and fronds that uncurl upward (van Wyk et al., 2002).  
 
1.7.1.1 Animal carcinogenicity, in vitro studies and in vivo studies 
P. aquilinum contains: (i) thiaminase I, which gives rise to a neurological disorder in horses and 
sheep; (ii) a carcinogen responsible for neoplasia particularly of the urinary bladder of cattle; and 
(iii) a cyanide-producing glycoside, prunasin (Kofod and Eyjolfsson, 1966 and Kellerman et al., 














the first of these, named ptaquiloside, was finally isolated simultaneously in Japan and The 
Netherlands (Niwa et al., 1983 and Van der Hoeven et al., 1983). Bracken is most often implicated 
as a cause of haemorrhagic tendencies and bone marrow suppression in cattle. 
 
Ptaquiloside destroys bone marrow, therefore it reduces: (i) the production of blood platelets which 
leads to internal bleeding; and (ii) white blood cells, which makes the animal susceptible to 
infections (Vahrmeijer, 1981). It is possible to reproduce the following: (i) acute bracken poisoning 
in calves; (ii) induce papillary, anaplastic and adenocarcinomas in mammary glands and ileum of 
Sprague-Dawley rats; (iii) induce mutations in Drosophila melanogaster and (iv) chromatid 
exchange-type chromosomal aberrations in hamster lung fibroblast cells (Hirono et al., 1984a, 
1984b; Matsuoka et al., 1989 and Sato et al., 1991). The consumption of bracken fern as food is 
associated with a high incidence of cancer in humans and animals (Almeida Santos et al., 2006). 
 
The cytogenetic effects of bracken fern extract (hexane extract-HE, ethanol extract-EE, hot water 
extract and cold water extract-CWE) on the chromosomes of the peritoneal and bone-marrow cells 
of Swiss mice were investigated by Almeida Santos et al. (2006). The peritoneal cells were found 
to be susceptible to structural (clastogenic) chromosome aberrations with all four treatments and 
numerical (aneugenic) chromosome aberrations with the EE treatment. On the other hand, bone 
marrow cells showed only structural chromosome aberrations with HE and CWE treatments. 
Bracken fern extracts can be clastogenic or aneugenic, depending on the tissue cell assay, and it 
might be speculated that bracken fern induced cancer can be modulated by chromosome 
aberrations (Almeida Santos et al., 2006). 
 
1.7.1.2 Human carcinogenicity 
In Japan, the crosiers (young bracken leaves with coiled hook-shaped tips) are eaten with soda 
ash (sodium bicarbonate) to remove the bitterness caused by the high tannin content and the 
presence of a cyanogenic glucoside, prunasin, in considerable quantity. The culinary name for this 
dish is Warabi; the local industrial production is from the crosiers of the toxic latiusculum variety, 
which may contain13 to 169kg of pure ptaquiloside per 13000 metric tons of crosiers (Alonso-
Amelot and Avedano, 2002). Although bracken ptaquiloside is sensitive to heat and alkali, it was 
possible to show that after such preparation, the crosiers from this treatment still retained part of its 
carcinogenic potential in rats (Hirono et al., 1972). A case-control study of upper alimentary tract 
cancer, comprising of 98 cases and 480 age-matched controls, revealed that the daily 
consumption of Warabi was associated with an almost threefold greater risk of developing 
oesophageal cancer (Kamon and Hiryama, 1975 and Hirayama, 1979). 
 
In some regions of Brazil P. aquilinum is consumed as “broto da Samambaia” where it is prepared 













Ouro Preto in Minas Gerais, a case-control study was undertaken in view of the high incidence of 
gastric and oesophageal cancers in people living in the area (Marliere et al., 1998, 2000). 
Examination by endoscopy of eaters and non-eaters of bracken (86 cases) indicated a risk for the 
development of upper alimentary tract neoplasias in those who consumed bracken. Furthermore, a 
weak but significant cancer protecting activity of bracken crosiers was found when eaten with a 
frequency of one meal per month or less. However such an association would need to be 
confirmed in a larger study, with greater power. Nevertheless, the correlations obtained thus far are 
sufficiently strong to associate direct bracken consumption by people to the onset of cancer of the 
upper alimentary tract (Alonso-Amelot and Avendano, 2002). 
  
1.7.1.3 Structure of ptaquiloside, key metabolites and related carcinogenicity 
Ptaquiloside has the structure of an illudane with a glucose moiety attached at carbon C4. The 
younger and softer the frond (crosier) the greater the content of this illudane (Fig 3. compound 1). 
Ptaquiloside is unstable  
(i) when separated from the plant   
(ii) under mild base or acid conditions 
(iii) in acidic pH, ptaquiloside is converted to the harmless pterosin B (Fig 3. compound 4a).  
 
Under conditions (i) and (ii) above, ptaquiloside (Fig 3. compound 1) converts with the loss of the 
glucose moiety into pteridienone, also referred to as illudane-dienone or dienone (Fig 3. compound 
2) or to ptaquiloside’s aglycone ptaquilosin (Fig 3. compound 3) (Kigoshi et al., 1989, 1993 and 
Padwa et al., 1994). Ptaquilosin is also unstable under the same conditions (i and ii) and converts 
into the same dienone, hence suggesting that other driving forces must be contributing to this 
transformation (Alonso-Amelot and Avendano, 2002). 
 
Fig 3. Structures of the carcinogenic component of bracken, key metabolites and a synthetic 
analogue: (1) ptaquiloside; (2) key metabolite is dienone commonly referred to as illudane-dienone 
or pteridienone; (3) synthetic analogue ptaquilosin (4a) is pterosin B and (4b) is pterosin F, which is 













Pteridienone has a more pronounced activity over ptaquiloside, which is in line with its increased 
alkylating capacity (Matsuoka et al., 1989). 
 
Ptaquiloside is designed to cross both lipid and hydrophilic barriers, as its aglycone portion enables 
its solubility in chloroform, methylene chloride, acetonitrile and methanol, whereas the glucose 
fragment facilitates its dilution in water. It is therefore conceivable that ptaquiloside can penetrate 
deeply into tissue and cells to reach the endoplasmic reticulum and nuclear DNA. This has led to 
the development of experiments to detect in vivo DNA-ptaquiloside alkylation adducts in the 
intestine and urinary bladder of ruminants.  
 
A P1-nuclease enhanced 32P-postlabelling assay revealed that ptaquiloside-DNA alkylation 
occurred only in specific organs, such as the ileum and urinary bladder, precisely the organs more 
prone to bracken-induced carcinogenesis in cattle (Reddy and Randerath, 1987 and Alonso-
Amelot and Avendano, 2002). The contents of the ileum and bladder are alkaline and provide ideal 
conditions for the transformation of ptaquiloside reaching the area into the strongly alkylating 
pteridienone. The ptaquiloside induction of carcinogenesis in ruminants occurs in organ-provided 
conditions (alkaline) for dienone formation followed by early H-ras mutations, and the true 
carcinogen is pteridienone rather than ptaquiloside.  
 
The H-ras gene in the target organ has shown an adenine to pyrimidine mutation on codon 61 (N3 
position) and guanines have been alkylated at N7 but at a reduced rate. Intravenous administration 
of pteridienone in rats induced tumours and a 32P postlabelling assay indicated that the ileum of all 
treated rats contained DNA adducts (Shahin et al., 1998). The genotoxicity and onset of cancer by 
P. aquilinum is illustrated in Fig 4. Depurination and DNA fragmentation is a destructive 
consequence of ptaquiloside assault that DNA synthetases find difficult to repair (Alonso-Amelot 
and Avendano, 2002).  
 
Once the structure of ptaquiloside became known, a reliable and sufficiently sensitive analytical 
procedure for its chromatographic detection became available (Agnew and Lauren, 1991). The 
HPLC chromatographic method was used to quantify the carcinogen in milk from cows feeding on 
bracken. Since the illudane is prone to decomposition by moderate heat, base or acid, the 
detection of ptaquiloside in milk from cows fed bracken fronds was accomplished by forcing the 
decomposition of ptaquiloside in milk to pterosin B, by treating with dilute alkali followed by mild 
acid and then analysing for pterosin B. The pasteurisation of milk may reduce the concentration of 
















In summary, the three possible routes of entry for carcinogens into the human body are through 
the consumption of milk and plant material and the inhalation of spores (powdery brown mass on 
the lower side of leaves). If bracken does contribute to the incidence of cancer it should be 
associated chiefly with two organs: (i) the respiratory organs, causing respiratory neoplasias 
resulting from the inhalation of spores that are windborne in large masses; and (ii) the organs of 
the upper alimentary tract in which swallowed spore carcinogens and bracken frond illudanes 
would have a higher chance of forming adducts with epithelium cells before being destroyed by 
acidic and/or alkaline media along the mid-digestive tract (Alonso-Amelot and Avendano, 2002). 
Bracken fern is important in this study because there is overwhelming evidence from in vitro, in 
vivo and epidemiological studies spanning three decades which shows a risk for the development 
of cancer of the upper alimentary tract from the ingestion of this plant. 
 
Fig 4. Flowchart of genotoxicity and onset of cancer by P. aquilinum illudanes (Alonso-Amelot and 
Avendano, 2002) 
 
1.7.2 Zantedeschia aethiopica  
Z. aethiopica belongs to the Family: Araceae. It is exceptionally common and occurs over a large 
part of South Africa, predominantly in wetlands. The leaves are used to cover wounds and the 
flowers are frequently used for ornamental purposes (van Wyk et al., 1997). The leaves of Z. 
aethiopica have a unique mannose-binding lectin with the ability to bind to cell membranes that are 
often toxic and occur mainly in seeds (van Wyk et al., 1997 and Chen et al., 2004). Mannose-
specific lectins are widely distributed in higher plants and are believed to play a role in the 
recognition of high-mannose type glycans of foreign microorganisms or plant predators (Barre et 
al., 2001). Catalase (E.C 1.11.1.6) has been purified from the leaves of Z. Aethiopica. This is a 
common enzyme found in nearly all living organisms and, in the textile industry, it is applied to 
fabric that has undergone bleaching with hydrogen peroxide for the elimination of hydrogen 















1.7.2.1 Active ingredients and pharmacological effects 
The active principle varies from species to species but always includes calcium oxalate. The 
harmful effects of oxalate produced upon ingestion depend on (i) concentration and (ii) whether 
oxalate is present in a soluble or insoluble form. Low to moderate levels of soluble oxalate are less 
toxic, however at high levels in the plant, the soluble oxalate is very harmful when eaten since it is 
readily absorbed from the digestive tract, reacts with blood calcium, causes ionic imbalance and 
decreases the coagulatory properties of the blood leading to internal haemorrhage, nephritis and 
renal failure (owing to a rapid accumulation of insoluble calcium oxalate crystals in the kidney 
tubules) and eventual death (Blackwell, 1990 and Lewis, 1998). When plants containing the 
insoluble form of oxalate are consumed, the crystals may become lodged in the mucous lining of 
the mouth and throat causing burning, irritation and swelling with the symptoms disappearing 
within a few days (Blackwell, 1990). All parts of Z. aethiopica are toxic and can cause severe 
irritation of the mucous membranes, with swelling of the tongue and throat, salivation, nausea, 
vomiting and diarrhoea (Lewis, 1998; van Wyk et al., 2002). 
 
 
Fig 5. Z. aethiopica is commonly referred to as the arum lily and is found from the Western Cape 
through the Eastern Cape, KwaZulu-Natal, Mpumalanga and into the Northern Province. The 
flowers are large and are produced in spring, summer and autumn, with a pure white spathe and a 
yellow spadix, and are often used for ornamental purposes (Van Wyk et al., 1997). 
 
1.7.3 Acokanthera oppositifolia  
A. oppositifolia is a member of the family, Apocynaceae, which is well-known for its alkaloidal 
content, indole alkaloids derived from tryptamine and steroidal alkaloid (C21 alkaloids) derived from 
pregnane, as well as for their potent pharmacological activity (Van Wyk et al., 2002 and Gurib-
Fakim, 2006).  
 
A. oppositifolia is well known throughout Africa as a traditional source of extremely toxic arrow and 














meat from an animal that has died from cardiac glycoside poisoning. The poison obtained from 
roots, leaves or wood can lead to death in humans within 15 minutes (van Wyk et al., 2002).  
 
   
         A          B 
Fig 6. A. oppositifolia is a medium to large woody shrub with attractive hardy dark green leaves. 
Clusters of pinkish white, sweetly scented flowers (B) are borne in late winter and spring and are 
followed by large plum-coloured berry-like fruits (A) which are relished by birds (van Wyk et al., 
2002). 
 
The leaves of A. oppositifolia are used in the form of snuff to treat headaches and in infusions for 
abdominal pain, convulsions (van Wyk and Gericke, 2000) and snakebite (Watt and Breyer-
Brandwijk, 1962). A. oblongifolia (Hochst.) Codd, a different but related species, prepared by 
sequential extraction with dichloromethane followed by 90% methanol induced DNA damage in 
human white blood cells using the alkaline comet assay (Taylor et al., 2003).  
 
1.7.3.1 Active ingredients and pharmacological effects 
A. oppositifolia are characteristic for their cardiac glycosides, the plants indigenous to South Africa 
have the following chemical composition: 
(i) seeds: the major component is water-insoluble acovenoside A (Fig 7.), two polar water-soluble 
glycosides, acolongifloroside K and acovenoside C, and trace amounts of ouabain (or absent). 
(ii) stems and twigs: large amounts of acovenoside A and acolongifloriside K (Neuwinger, 1996).  
The amount of the minor component, ouabain (Fig 7.) obtained from Acokanthera sp, varies in 
different parts of Africa: trace amounts of ouabain (or absent) from A. oppositifolia in South Africa 
and Kenya/Nairobi, whereas a higher content of ouabain is present in A. schimperi from 
Kenya/Nairobi (Neuwinger, 1996).  
 
In a study carried out by Wangenheim and Bolcsfoldi (1988), ouabain was positive for mutagenicity 
in a mouse lymphoma L5178 thymidine kinase assay in the absence of metabolic activation at a 
dose of 0.103-8.22mmol/l; with 2-4 fold increase in the mutation frequency. From their study, 
potent mutagenic/carcinogenic compounds tested had greater than 4-fold increases in the 
mutation frequency, whilst weak carcinogens or compounds not known to be carcinogenic that was 













increase in the mutation frequency was associated with a lower predictivity for carcinogenicity. A 
high in vitro cytotoxic activity was obtained for acovenoside A and acolongifloroside K, but no in 
vivo activity was obtained for these compounds (Kingsten and Reichstein, 1974).  
 
Fig 7. Molecular structures of acovenoside A and ouabain (van Wyk et al., 2002) 
 
Ouabain has pharmaceutical significance as a cardiac glycoside for the treatment of heart ailments 
and is administered intravenously because it is very poorly absorbed in the digestive tract (van 
Wyk and Wink, 2004). Cardiac glycosides can be divided into two classes, cardenolides and 
bufadienolides, the former being extremely toxic with doses being carefully adapted to individual 
needs by health care professionals. The plant extract is lethal because the concentration and 
dosage of the active principles cannot be controlled. 
 

















Fig 8.  R. lanceolatus is a weed found in seasonally wet places and occurs in many parts of 














Rumex sp (Family: Polygonaceae) occurs widely in southern Africa and the leaves are popular as 
a dietary supplement and are served as “sorrel” or cooked with porridge. Both R. lanceolatus and 
R. crispus are equally popular as medicinal plants (van Wyk et al., 1997).Infusions and decoctions 
of this plant are traditionally used to treat constipation, liver problems and arthritis, with the root 
being used as a remedy for internal parasites (tapeworm and roundworm). It is also regarded as a 
cleansing herb and used to treat chronic skin problems. The whole plant is said to be widely 
employed for vascular disorders and internal bleeding (van Wyk and Wink, 2004). Externally it is 
applied to ulcers, boils and tumours.  
 
1.7.4.1 Active ingredients and pharmacological effects 
Many Rumex sp contain anthraquinones, with the exception of one species having been found to 
date, namely R. induratus (Ferreres et al., 2006). R. lanceolatus is a mild purgative containing 
chrysophanic acid, emodin (Fig 9.) and a small amount of volatile oil; neither alkaloid nor glucoside 
are present (Watt and Breyer-Brandwijk, 1962). Roots of Rumex sp contain glycosides of emodin 
and chrysophanol (such as chrysophanein, Fig 9.) and tannins (van Wyk and Wink, 2004). The 
laxative effect of the roots of Rumex sp is due to chrysophanol and related anthracene glycosides.  
 
Fig 9. Molecular structures of chrysophanol, chrysophanein, emodin and oxalic acid (van Wyk et 
al., 1997 and Lee et al., 2005) 
 
Oxalic acid (Fig 9.) is typical of Rumex sp and the leaves contain large amounts of it (van Wyk et 













medicinally as a haemostatic agent in the form of a 5% solution in 5% malonic acid (van Wyk and 
Wink, 2004). 
 
Rumex species are related to the well-known medicinal plants known as rhubarbs, which are a 
group of plants that belong to the genus Rheum in the family Polygonaceae (van Wyk and Wink, 
2004). Several monomeric anthraquinones, such as emodin (1,3,8-trihydroxy-6-methyl-
anthraquinone) and related derivatives, are constituents of rhubarb (an oriental medicine for 
diarrhoea) that exhibit mutagenicity in the Salmonella/microsomes test and cultured tumour cells 
(Morita et al., 1988 and Ueno, 1991). However, emodin from the aerial parts of R. acetosa strongly 
inhibits the proliferation of tumour cell lines, and shows antimutagenicity (in strains TA 98 and 
TA100) and antigenotoxic activity (Lee et al., 2005).The OH group at the C-6 position in the 
anthraquinone nucleus may play an important role for their cytotoxicities, and an introduction of 
OH- or OCH3 group at C-6 position is necessary for their antimutagenic activities (Lee et al., 2005). 
 
The rhizome of R. crispus L. contains volatile oil, resin, tannin, rumicin, sulphur, starch, various 
other salts, lapathin, oxymethylanthraquinone, emodin and chrysophanic acid (Watt and Breyer-
Brandwijk, 1962). The tannin content of the rhizome is so high that the plant was at one time 
considered a possible commercial source of tannin. The phytochemical screening of the powdered 
root of Rumex steudlii Hochst shows the presence of polyphenols, pytosterols, O-anthraquinone 
glycoside, tannins, hydrolysable tannins and saponins, but the test for alkaloids shows a negative 
result (Gebrie et al., 2004). 
 
1.7.5 Pelargonium sp. 
Pelargonium sp (Family: Geraniaceae) is used for its commercial and medicinal value. Rose-
scented geranium (Pelargonium species) is a high-value, aromatic plant cultivated for its essential 
oil, which is widely used in the fragrance industry, in aromatherapy and for the extraction of 












Fig 10. Leaves of Pelargonium sp. cf. inquinans (L.) L’ Herit. Pelargonium sp. are cultivated for 















The essential oil is obtained using steam or water as well as steam distillation of shoot biomass 
(Rao et al., 2002). Root extracts are used in preparations to treat acute and chronic infections of 
the nose, ears and chest, and have been found to be particularly effective for bronchitis in children 
and as a supportive treatment for tuberculosis and chronic bronchitis (van Wyk and Wink, 2004). 
The leaves and roots are also used for the treatment of dysentery and syphilis. Isoquercetrin and 
rutin, respectively the major and minor flavonoids obtained from Pelargonium radula (Cav.) L’Herit, 
have been shown to have antimicrobial activity (Pepeljnjak et al., 2005).  
 
1.7.5.1 Active ingredients and pharmacological effects 
The main ingredients of Pelargonium sp. are coumarins (Fig 11.); mainly 7-hydroxy-5,6-
dimethoxycoumarin, that co-occur with at least seven other coumarins, gallic acid derivatives 
(including gallic acid and gallic acid methyl ester), oligomeric proanthocyanidins, and flavonoids: 
flavan-3-ols (e.g. catechin) and flavon-3-ol (e.g. quercetin) (Middleton et al., 2000 and van Wyk 
and Wink, 2004).  
 
Fig 11. Chemical structure of coumarin (Culvenor and Jago, 1979) 
 
Pelargonium oils contain a variety of monoterpenoids, such as geraniol, (+)-isomethone, citronellol 
and phenylethyl alcohol (responsible for the rose smell). The gallic acid derivatives and other 
phenolic compounds in the roots have powerful antibacterial and antiviral activity, and together with 
coumarins provide a rationale for the proven immunomodulatory activity. 
 
The five South African (SA) plants discussed above have not been previously evaluated for 
mutagenicity. In countries where P. aquilinum has been consumed as a food, in-depth scientific 
investigations have concluded that ptaquiloside and its metabolically activated intermediate, 
pteridienone, play a role in the carcinogenic process. It is inevitable that mutagenicity and 
clastogenicity will be anticipated for the SA P. aquilinum, which can be evaluated with the selected 
in vitro mutagenicity tests. 
 
1.8 In vitro mutagenicity assays 
1.8.1 Salmonella reverse mutation assay 
The Salmonella reverse mutation assay is an initial screen to determine the mutagenic potential of 













mutagenic response is obtained. In the Salmonella reverse mutation assay, the test substance is 
added to the top agar (minimal medium) containing S9, a bacterial tester strain and a minimal 
amount of histidine to support a few cycles of replication, but not enough to permit colonies to form. 
The molten top agar is poured onto solid media and incubated (48hrs/37oC). In the presence of the 
mutagen, the strain reverts to wild type (his+) thereby allowing colonies to form on the minimal 
medium. The number of colonies can be related to controls and to the amount of the test 
substance used to give a quantitative result. A twofold rule usually applies when the number of 
colonies of the test chemical is twice the amount on the control plate and the test chemical is 
mutagenic. 
 
Bacterial strains were originally derived from Salmonella typhimurium LT2. The bacteria carry a 
mutation (his-) that makes them nutritionally deficient because they cannot synthesise one of the 
enzymes needed to manufacture histidine, which is supplemented in the top agar. The genotypes 
and related characteristics of the primary tester strains are indicated in Table 3. The Salmonella 
strains used in the test have different mutations in various genes of the histidine operon; each of 
these mutations is designed to be responsive to mutagens that act via different mechanisms 
(Mortelmans and Zeiger, 2000). TA97a and TA98 detect frameshift mutagens, whilst TA100 
detects mutagens that cause base-pair substitutions (Maron and Ames, 1983). TA102 detects 
mutagens that cause oxidative DNA damage, and being a DNA repair proficient strain, detects 
cross-linking agents such as bleomycin and mitomycin C (Mortelmans and Zeiger, 2000).  
 











Strain TA98 Strain 
TA100 
 rfa deletion uvrB 
deletion 
+R 















   
(*R-factor plasmid pKM101 confers ampicillin resistance, **pAQ1 confers tetracycline resistance.  
LPS: lipopolysaccharide layer prevalent in gram negative bacteria, rfa deletion makes the cell wall more 
permeable to the penetration of chemicals). Source: adapted from Maron and Ames (1983) and Mortelmans 
and Zeiger (2000) 
 
A chemical can be scrutinised for its ability to achieve one or more kinds of genetic alteration, 
resulting in reversion from his- to his+, and is taken as a measure of an agent’s mutagenic and 
carcinogenic potential. Since many substances are unable to pass through bacterial cell walls, the 
strains used carry a mutation that makes the wall more penetrable to chemicals (rfa). The strains 
TA97a, TA98 and TA100 also carry another mutation that causes a defect in the DNA repair 














incompetent, and permit the easier detection of various kinds of alteration in the DNA, since a 
defect will not be repaired. 
 
1.8.2 Chromosomal aberration test 
The effects of plant extracts on chromosome structure (clastogenicity) were evaluated in peripheral 
blood lymphocyte cultures with and without S9. DNA damage is assessed from metaphase-
arrested cells (Fig 12.), therefore chemicals that inhibit mitosis or are indirect mutagens via non-
DNA targets such as the spindle inhibitors cannot be analysed with the chromosomal aberration 
test. A structural chromosomal aberration comprises two types: chromosome aberration (CSA) 
when both chromatids are damaged at the same loci and chromatid aberrations (CTA) when one 
chromatid is affected. The CSA and CTA types arise from cell-cycle progression (G1, S, G2 and M) 
and in relation to S-phase independent or dependent clastogens.  
 
Fig 12. The cell cycle is divided into the interphase, when cellular components are replicated, and 
mitosis, when the cell splits into two, distributing its contents into two progeny cells. The interphase 
is divided into two gap phases (G1 and G2) when the cell duplicates specific molecules and 
structures, and a synthesis phase (S) when it replicates its DNA. Checkpoints ensure that the cycle 
proceeds correctly. The first checkpoint, between the G1 and S phases, monitors signals from 
inside and outside the cell to determine whether conditions are right for DNA duplication. The 
second checkpoint, just before mitosis, ensures that the chromosomes are completely replicated 
and that errors in the new DNA sequences are repaired (Lewis, 1997). 
 
The mechanisms for the formation of CSAs and CTAs viewed at metaphase are cited in various 
publications (Savage 1975, Albertini et al., 2000, Savage 2004, Hagmar et al., 2004 and Mateuca 
et al., 2006) and are summarised below:  
(i) CSAs result from incompletely repaired or unrepaired double-strand breaks (DSBs) 













(e.g. ionising radiation). After DNA synthesis and chromosome duplication at S-phase, 
the aberrations formed in Go–G1 are seen as chromosome-type breaks in the 
metaphase.  
(ii) CTAs (e.g. chromatid-type breaks) arise predominantly in vitro during the G2-phase of 
the cultured lymphocytes in response to base modifications and single-strand breaks 
(SSBs) induced by S-phase-dependent clastogens (e.g. chemicals).  
 
The extensive use of the chromosomal aberration assay over the last 30 years has resulted in the 
accumulation of analytical data in many European laboratories and has enabled the examination of 
the potential association between previously measured structural chromosomal aberration 
frequency and subsequent cancer outcome (Bonassi and Au, 2002). The impact of CSAs and 
CTAs from smoking and other environmental carcinogens on human cancer risk has been recently 
assessed, because originally the study did not have sufficient power and/or follow-up time for a 
conclusive result with respect to cancer predictivity. In the Taiwanese and Nordic cohorts, CSAs 
but not CTAs predict cancer risk; however, in the Italian cohort no clear-cut difference in cancer 
predictivity between CSA and CTA biomarkers was observed (Liou et al., 1999 and Hagmar et al., 
2004). Evidence from a recent study conducted by Norppa et al. (2006) indicates that both 
chromatid-type and chromosome-type aberrations predict cancer; even though some data suggest 
that chromosome-type aberrations may have a more pronounced predictive value than chromatid-
type aberrations. 
 
1.8.2.1 The distinction between gap junction and chromosome breaks 
Light microscopy is used to detect structural chromosomal aberrations (gaps and breaks) from 
metaphase-arrested lymphocytes.  
 
Fig 13. Structural chromosome aberrations by light microscopy of metaphase arrested cells: (a) 
chromatid constriction; (b) chromatid gap; (c) chromosome constriction; (d) constriction/gap; (e) 
chromosome gap; (f–h) examples of aligned chromatid breaks; (i–l) examples of dislocated 
chromatid breaks; (m) chromosome break with complete sister-union (SU); (n) chromosome break 
with incomplete sister-union (Nup or Nud); (o) chromosome break with no sister-union (Nupd), or a 














The distinguishing features of gaps and breaks applied to the scoring of metaphase cells was 
according to Savage (2004). The following features are characteristic of a break: (i) the non-
staining region is larger than the width of a chromatid; (ii) the distance between the broken “ends” 
of a chromatid has no visible connection (Fig 13. f–h); and (iii) there is non-alignment, or 
dislocation, of the two segments (examples Fig 13. i–l). An aberration is referred to as a gap when 
the non-staining region is smaller than the width of a chromatid and little chromatin may be evident. 
The visual non-staining region of a gap does not imply that chromatin is absent; in such instances, 
chromatin is seen in the non-staining region under the electron microscope. 
 
1.9 Overview of the study 
Traditional plants or extracts consumed for their medicinal or dietary value are assumed to be safe 
because they occur naturally. This study looked at the potential mutagenicity of five commonly 
consumed traditional plants, as there is a huge body of evidence that disproves the theory that 
natural equates to safe. In addition, there is a high incidence of late-onset oesophageal cancer 
among the population of the Eastern Cape Province of South Africa where traditional 
plants/extracts are more frequently consumed. The rationale and justification for this research are 
that the five traditional plants in this study are part of the diet in this population; there is no prior 
research in this field with the exception of a South African epidemiological study (Sewram, 2006) 
which supplements this dissertation. 
 
The research problem (hypothesis) is to identify those traditional plant extracts that damage DNA 
(mutagenic agents) and chromosomes (clastogenic agents) using in-vitro quantitative test 
methods. The five traditional plants investigated were Acokanthera oppositifolia (Lam.) Codd; 
Pelargonium cf. inquinans (L.) L’ Herit; Pteridium aquilinum subsp aquilinum; Rumex lanceolatus 
Thunb. and Zantedeschia aethiopica (L.). This is a screening study of the potential mutagenicity of 
aqueous extracts and not a phytochemical study. Simplified versions of two of the three in vitro 
genotoxicity screening assays currently recommended by the International Conferences on 
Harmonisation of Technical requirements for registration of Pharmaceuticals for Human Use (ICH 
Guidance S2B): (i) a bacterial mutation screening test (Salmonella reverse mutation assay) and (ii) 
a chromosomal aberration screening test in Chinese hamster ovary (CHO) cells (Zhang et al., 
2004) were selected, however in the present study peripheral blood lymphocytes were used 
instead of CHO cells. The tests were done with and without metabolic activation (S9 mix).   
 
Limitations of the Salmonella reverse mutation assay include that it cannot detect the mutagenicity 
of large molecules that cannot pass through the cell wall of the tester strain and it also fails to 
detect those carcinogens (e.g. Fumonisin B1) that are not mutagenic. The chromosomal aberration 
test was performed on peripheral blood lymphocytes, the limitations include interference from red 













monocytes and granulocytes, which resulted in very few metaphase cells for chromosomal 
analysis. The lymphocytes were stimulated to enter the cell cycle (G1, S, G2 and M) using 
phytohaemagglutinin followed by metaphase arrest using colcemid. The test was not suitable for 
extracts that inhibited the cell cycle, which was an additional limitation. Following Savage (2004), 
approximately 50 metaphase cells were scored for chromosomal aberrations (gaps and breaks).  
 
The data were collected by measuring the two endpoints (mutagenicity and clastogenicity) at 
increasing concentrations of aqueous plant extracts with and without metabolic activation (refer to 
section 1.3). In the Salmonella reverse mutation assay, a reversion to wild type with an associated 
three- to fivefold increase in the number of revertant colonies indicated mutagenicity. Four 
Salmonella tester strains (TA97a, TA98, TA100 and TA102) were selected, each indicative of a 
particular kind of mutation: base-pair substitution, frameshift or oxidative DNA damage. The 
baseline revertant colonies for TA102 were the highest (fivefold) relative to the other three tester 
strains. Batch TA102 complied with the supplier’s release criteria; the baseline reversion frequency 
had increased over the years when compared to that of the original tester strains (email 
correspondence with the supplier, Appendix C). The mutagenicity data were analysed by a 
professional statistician using gamma statistics, whilst the clastogenicity data were not statistically 
analysed owing to the low number of metaphase cells. In light of the evidence provided the 
mutagenic potential of five South African plants currently being used in traditional medicine and/or 

































MATERIALS AND METHOD 
 
2.1 Collection of plants 
The plants Acokanthera oppositifolia (Lam.); Pelargonium sp. cf. inquinans (L.) L’ Herit;  
Pteridium aquilinum subsp aquilinum; Rumex lanceolatus Thunb. and Zantedeschia aethiopica (L.) 
Sg. were obtained from Port St Johns in the Eastern Cape, and the Silverglen medicinal plant 
nursery in KwaZulu-Natal during November 2002. The identities of the plants were authenticated 
by comparison with reference specimens at the Kei Herbarium (Walter Sisulu University) and Natal 
Herbarium (National Botanical Institute, KwaZulu-Natal), and voucher specimens (see Table 5) 
were deposited in these herbariums for future reference. The leaves of all plants were air-dried, 
crushed by hand or cut with an Anvil pruner before they were milled into a fine powder using a 
Kenwood blender. A facemask was used to avoid inhalation of the dust during the handling and 
milling of plant material. The powdered material was weighed into brown paper bags, labelled and 
stored at room temperature.  
 
2.2 Preparation of plant extracts 
Milled plant material (30g) was weighed into a conical flask (1L), and then boiled in water (500ml). 
The plant material was agitated using a magnetic stirrer and boiled for 1hr. The plant extracts were 
cooled to room temperature and filtered twice using a Rundfilter MN617 filter paper. The filtrate 
was transferred to a round bottom flask (1L) and refrigerated at -20oC overnight. The frozen filtrate 
was thereafter lyophilised and stored at 4 to 5oC in a dessicator; the mass of lyophilisate obtained 
is recorded in Table 4. 
 
Table 4. Plant processing and yield of freeze-dried extract (lyophilisate) 
Botanical name 
Part of plant 











Leaves 30g/500ml 4.33g 14.43 
Acokanthera oppositifolia (Lam). Leaves & stems 30g/500ml 5.27g 17.57 
Pelargonium L. Herit Leaves & stems 30g/500ml 4.18g 13.93 
Rumex lanceolatus Thunb. Leaves & stems 30g/500ml 4.76g 15.87 
Zantedeschia aethiopica (L.) Sg Leaves & stems 30g/500ml 5.29g 17.63 
 
The freeze-dried material (0.8g) was dissolved in sterile distilled water (10ml), sonicated for 20min, 
centrifuged at 4000rpm for 10min at 0oC and the supernatant decanted into a 25ml beaker. The 
supernatant was transferred into a scintered glass filtration apparatus containing a 5-micron 
cellulose filter. The filtrate was re-filtered through a 1.2-micron filter. The solution was finally filter 
sterilised through a 0.2µm syringe filter into a sterile bijou bottle from which dilutions were made 
using sterile water by aseptic handling to avoid test sample contamination. The following dilutions 




























and R. lanceolatus, and (ii) 0.00125; 0.0025; 0.005; 0.01 and 0.02g/ml for Z. aethiopica as a result 
of the highly viscous nature of this extract. 
 
2.3 Preparation of S9 
2.3.1 Induction of rat liver enzymes 
Approval for the experimental protocol was granted by the Ethics Committee for Research on 
Animals (ECRA) of the Medical Research Council, Tygerberg, South Africa. Fifteen rats weighing 
200 to 300g were administered with Aroclor 1254, a polychlorinated biphenyl (PCB) and a known 
carcinogen, based on a procedure by Czygan et al. (1973). Aroclor 1254 was warmed in a 20oC 
waterbath, and 3.0g weighed into a 25ml measuring cylinder. Warm sunflower oil was added to the 
measuring cylinder to a volume of 15ml and homogenised by aspiration with a pipette. This yielded 
a 200mg/ml Aroclor 1254 working stock solution which was dispensed into two 7ml bottles fitted 
with rubber bungs and sealed with metal rings. The bottles were covered in foil to avoid 
degradation of the light-sensitive PCBs. All pipettes and glassware, including the 25ml measuring 
cylinder, were discarded as carcinogenic waste. The viscous Aroclor 1254 working stock was 
immersed in warm water during intraperitoneal injection into rats. The Aroclor was administered at 
500mg/kg body weight using a 26G needle for intraperitoneal injection. This procedure was 
repeated for all fifteen rats.  
 
2.3.2 Preparation of liver homogenate S9 fraction 
On the seventh day after induction the rats were sacrificed by cervical dislocation and the livers 
removed by midline incision, according to Maron and Ames (1983). Instruments for the dissection 
(forceps and scissors) were sterilised by autoclaving (121oC/20min) and iodine was used as a 
disinfectant during excision of livers. Preparation of the liver S9 fraction is based on the procedure 
of Garner et al. (1972). All steps were carried out on ice and using sterile solutions (cold). 
Glassware and centrifuge tubes were autoclaved prior to use. The centrifuge tube caps were 
sterilised in 70% ethanol as they were not autoclavable. Frequent disinfection of surfaces during 
S9 preparation was attained by application of 70% aqueous ethanol.  
 
The excised livers were washed in pre-weighed 1L beakers containing 400ml cold sterile KCl 
(0.15M) to remove haemoglobin, covered with foil and kept on ice. The livers (a total mass of 
206.5g) were transferred into a beaker containing 3ml of chilled 0.15M KCl per gram of wet liver, 
and cut into smaller pieces. The liver was homogenised for 5min with a Polytron homogeniser (PT 
3000, Kinematica AG). The liver homogenate was then filtered through sterile double-layered 
cheesecloth into a 500ml beaker to remove larger pieces of tissue while working on ice. The filtrate 
collected in the beaker was transferred to an all-glass dounce homogeniser, and dounced by 10 
strokes of the plunger to release the microsomes. The homogenate was then centrifuged at 9000g 












dispensed in 3ml and 5ml aliquots into sterile bijou bottles and immediately stored at -70oC, and 
the pellets were discarded. The S9 was tested for sterility, protein concentration and CYP P450 
activity. The absence of colonies on a nutrient broth agar plate after inoculation and incubation at 
37oC for 24hrs indicated a sterile S9 preparation.  
 
2.3.3 Protein concentration of S9 
The protein concentration was determined by the Bradford method (1976). A standard curve was 
constructed using known amounts of bovine serum albumin (BSA). One hundred microlitres of a 
1:100 S9 dilution was used for the Bradford test. The BSA standards 8, 16, 24, 32 and 40ug and 
the S9 sample were prepared in duplicate, and measured at 595nm with an Uvikon 923 
spectrophotometer. The protein concentration of the S9 fraction was 27.1mg/ml.  
 
2.3.4 CYP P450 concentration of S9 
The CYP P450 concentration was determined by a method adapted from Omura and Sato (1964). 
The S9 was diluted 20x in a volume of 8ml by combining 400µl S9 with 7600µl Tris buffer (0.1M, 
pH7.4). The sample was saturated with a stream of carbon monoxide for 1min and placed in two 
cuvettes (4ml capacity) marked as reference and sample. The baseline absorbance was read at 
500-400nm at a sensitivity of 0.5 and 0.1 with a double beam Beckman spectrophotometer 
UV5260.  
 
Sodium dithionite (0.01298g) was added to the sample cuvette and dissolved by inversion several 
times. The observed bubbling, which was indicative of CYP P450, stopped before the difference 
spectrum was monitored (500nm and 400nm). The CYP P450 activity was determined from the 
450nm absorption peak using the following formula and the mmol extinction coefficient (91) of the 
compound.  
CYP P450 activity = (A450-490 - Correction of baseline)/100 X sensitivity X 1000/91 X 1/mg per ml protein 
         
                                    =               75.5 - (-8.6) / 100                      X      0.1      X  10.989   X  1/27.1   X    20 
                                                                                                                                                                  dilution factor 
                                    =                0.7nmol/mg 
 
The protein concentration (27.1mg/ml) was inserted into the formula. The value for “(A450-490 - 
correction of baseline)” was obtained from the difference spectra chromatograph (section 3.1.1). 
The CYP P450 activity calculated was 0.7nmol/mg. This was within the recommended range (0.6-
0.8nmol/mg), and therefore suitable for use in the mutagenicity assay. 
 
2.4 Verification of genotypes of Salmonella tester strains  
The verification of genotypes was done according to the method prescribed by Maron and Ames 
(1983) and Mortelmans and Zeiger (2000). Five microlitres of Salmonella tester strains: TA97a; 














(4.9ml) that was supplemented with antibiotics according to the procedure in Fig 14. Genotype 
verification was performed for his-, uvrB, rfa and antibiotic resistance markers. (Note: all solvents 
and media are listed in Appendix A.) 
 
Strains TA97a, TA98, TA100 and TA102 contain plasmid pKM101, which (i) confers ampicillin 
resistance that serves as a convenient marker for detecting the presence of the plasmid, and (ii) 
enhances chemical and UV-induced mutagenesis. In addition to pKM101, strain TA102 contains 
multicopy plasmid pAQ1. Plasmid pAQ1 confers tetracycline resistance and is a convenient marker 
for detecting the presence of the plasmid. Furthermore, the hisG428 mutation was inserted into 
pAQ1 with the aim of amplifying the number of target sites. 
 
2.4.1 Histidine dependence 
An aliquot of overnight culture (0.1ml) from each tube at step 4 (Fig 14.) was plated onto MGA 
plates supplemented with two drops of 0.01% w/v biotin. Because all Salmonella strains are 
histidine dependent, there should be no growth on the plates after incubation at 37oC for 16 to 
24hrs. Plates that display growth indicate that the colony from which the broth culture has arisen 
(in the masterplate) is unsuitable for the preparation of working cultures for the Salmonella reverse 
mutation assay. 
 
2.4.2 Biotin and histidine dependence  
MGA plates were supplemented with two drops of 0.01% w/v biotin and two drops of 0.5% w/v 
histidine by the spread plate technique described in Fig 14, step 2. A loopful of culture from each of 
the ten tubes was streaked onto the MGA plates and incubated at 37oC for 16 to 24hrs. Growth 
was expected to be observed with all strains since they are all histidine dependent. 
 
2.4.3 Biotin dependence  
MGA plates were supplemented with two drops of 0.5% w/v histidine. A loopful of culture from 
each of the ten tubes was streaked onto the MGA plates and incubated at 37oC for 16 to 24hrs. 
There should be no growth on the plate except for TA102, which is biotin independent since it has 
an intact bio gene, unlike the other tester strains where the uvrB gene deletion extends through the 
bio gene making them biotin dependent.  
 
2.4.4 rfa marker 
Sterilised low melting top agar (100ml) was supplemented with a sterile 0.5mM histidine/biotin 
solution (12ml). Aliquots of top agar (2.5ml) were dispensed into ten test tubes (with spring-loaded 
Cap-O-Test) and kept in a 45oC waterbath. A 0.1ml inoculum of culture was added to 2.5ml molten 















Fig 14. Flow diagram for genotype verification of Salmonella tester strains 
Step 1: the tester strains were inoculated into antibiotic-supplemented oxoid nutrient broth. 
Step 2: individual colonies from the broth culture were isolated on MGA plates supplemented with 
histidine, biotin and ampicillin (for strains TA97a, TA98 and TA100), and on MGA plates 
supplemented with histidine, biotin, ampicillin and tetracycline (for strain TA102) by a four-way 
streak.  
Step 3: ten colonies were transferred to a designated spot on MGA masterplates M1 and M2 
marked “A-J” and into 10ml oxoid nutrient broth tubes marked “A-J”.  
Step 4: after incubation the broth cultures were used for the genotype test whilst the masterplates 















(NBA) plates using a pour-plate technique. Paper discs (0.6mm) were made from Whatman No. 1 
using a paper punch and sterilised by autoclaving at 121oC for 20min. A single disc was placed in 
the centre of each plate and 5µl of 0.1% crystal violet were added to the disc. The plates were 
incubated at 37oC for 16 to 24hrs. A zone of inhibition indicates a positive result. The rfa deletion 











Fig 15. The zone of inhibition indicates crystal violet sensitivity. The rfa mutation permits large 
molecules such as crystal violet to enter and kill the bacteria. Wild-type strains are not inhibited 
because the crystal violet cannot penetrate the cell. All Salmonella strains should show a zone of 
growth inhibition surrounding the disc. 
 
2.4.5 uvrB deletion 
 
         












Fig 16. Strains with uvrB deletion will grow only on the un-irradiated side of the plate as seen for 
TA97a. The deletion mutation stretches across the bio-uvrB region of the chromosome. It shows 
that the tester strains are defective in the accurate DNA repair pathway due to the uvrB deletion. 
 
A loopful of inoculum from each of the ten tubes was streaked onto NBA plates. Covering half the 
plate with cardboard, irradiation with a 15W UV germicidal lamp (43.5cm in length) was applied for 
8 seconds at a distance of 33cm. No growth on the irradiated portion of the plate should be 
observed for TA97a, TA98 and TA100, since they do not have an intact uvrB gene. However, 













irradiation, petri plate lids were removed because the UV radiation does not penetrate the plastic. 
Plates were incubated at 37oC for 16 to 24hrs. 
 










Fig 17. Ampicillin resistance is a convenient marker for testing for the presence of the plasmid 
pKM101 since specific regions of the pKM101 DNA are essential for enhancing UV and chemical 
mutagenesis. With the sample on the right, the zone of inhibition indicates loss of the plasmid and 
thus is unsuitable for working culture preparation. 
 
Ampicillin resistance was used as a marker to test for the presence of plasmid pKM101, since 
specific regions of the pKM101 DNA are essential for the enhancement of UV and chemical 
mutagenesis. The pour plate technique described in section 2.4.4 was applied. An ampicillin disc 
(BBL Sensi-Disc Antimicrobial Susceptibility Test Discs, Ampicillin 10µg) was placed in the centre 
of each plate and incubated at 370C for 16 to 24hrs.The absence of a zone of inhibition around the 
disc demonstrates a positive result. 
 
2.4.7 Spontaneous mutation frequency 
A 0.1ml inoculum from each of the 10 culture tubes was seeded into top agar supplemented with a 
0.5mM histidine/biotin solution and overlayed onto MGA plates. The plates were incubated at 37oC  
 
Table 6:  The spontaneous revertant laboratory values in comparison to the values stipulated in the 
literature and by the supplier 
Strain Batch no. 









Minus S9 Plus S9 Minus S9 
TA97a Lot 517 220 ± 28 75-200 100-200 196-256 
TA98 Lot 518 39 ± 3 20-50 20-50 - 
TA100 Lot 519 187 ± 14 75-200 75-200 - 
TA102 Lot 520 564 ± 78 100-300 200-400 500-588 
a
 Values from the supplier’s (Xenometrix CA, USA) quality testing  
b
 The literature by Mortelmans and Zieger (2000) is recommended by the supplier. However, the exception is 
for TA97a and TA102 where the supplier values exceed the literature values (minus S9). The supplier 
indicates that the high values for TA97a and TA102 is because the spontaneous revertant frequencies have 














for 48hrs. A lawn of bacterial growth was observed at 24hrs and revertant colonies at 48hrs.The 
colonies were hand-counted using a Quebec darkfield colony counter. The spontaneous mutation 
frequencies of the tester strains cited in the literature (Mortelmans and Zieger, 2000) by the 
supplier and the values obtained in the laboratory are tabulated in Table 6. 
 
2.5 Preparation working culture and frozen permanents 
A colony that complied with the genotype verification and spontaneous mutant frequency from 
each tester strain was removed from the masterplate and seeded into oxoid nutrient broth No. 2 
(5.5ml) and incubated at 37oC overnight in an orbital shaker (Culture A). Working cultures were 
made by seeding Culture A (1ml) into sterile oxoid nutrient broth No. 2 (50ml) and incubated at 
37oC overnight in an orbital shaker. DMSO (5ml) was added to the working culture (50ml) and 
aliquots (1ml) were dispensed into sterile cryovials kept on ice and transferred to a -70oC freezer. 
For mutagenicity testing an aliquot of working culture (1ml) was thawed, seeded into oxoid nutrient 
broth (50ml) and incubated as previously described. Five “frozen permanents” were made by 
adding DMSO (0.5ml) to culture A (4.5ml), dispensed into 1ml aliquots kept on ice and stored at  
-70oC.  
 
2.6 Dose-response of tester strain to mutagen 
The dose-response of tester strains TA97a, TA98 and TA100 to increasing concentrations of 2-
acetamidofluorine (2-AAF) was done in quadruplicate using a standard pour plate technique. The 
purpose of the dose response was to (i) select a single concentration from the monotonic region of 
the graph that produced a two- to fivefold increase in revertant colonies than the spontaneous 
revertants for the purpose of a positive control and (ii) examine the strain’s responsiveness to 
mutagens. An overnight working culture (0.1ml) was seeded into histidine/biotin supplemented with 
top agar (2ml), followed by 2-AAF (0.1ml) and 4% S9 mix (0.5ml). The top agar was overlayed onto 
minimal glucose agar (MGA) plates and incubated at 37oC for 48hrs. Revertant colonies were 
hand-counted and the average of quadruplicate plates was plotted (refer to the results in section 
3.1.2). The dose-response in TA102 was done with cumene hydroperoxide (recommended by 
supplier), which is a directly acting carcinogen and as such requires no metabolic activation (S9). 
Dose response for TA102 was done in a similar manner with the exception that 2.5ml top agar was 
used instead of 2ml.  
 
2.7 Salmonella reverse mutation assay 
The Salmonella reverse mutation assay was performed in quadruplicate with TA97a, TA98, TA100 
and TA102 (with and without S9) for the following reasons: (i) maximum detection of mutagenic 
compounds; (ii) is favourable for statistical analysis; and (iii) allows for comparisons to be drawn. 
The tester strains, TA97a and TA98, are designed to detect frameshift mutations, TA100 for the 













crosslinking and transition transversion reactions. The use of four tester strains increased the 
likelihood of detecting a test substance capable of mutagenesis by either one or more of the 
mechanisms described above. Bacteria are unable to metabolise chemicals via cytochrome P450, 
as in mammals and other vertebrates, and a key component for making the bacterial mutagenicity 
test useful was the inclusion of an exogenous mammalian metabolic activation system consisting 
of an extract of rat liver (S9). 
 
An extract was mutagenic if the average number of revertants per plate (mean of 4 or 3 replicate 
plates) was at least doubled over the spontaneous revertant frequency and is in keeping with the 
two- to threefold rule. If the revertant count of a dose-response curve of test chemical exceeds 
twice or thrice the spontaneous background rate, the two- to threefold rule determines the test 
result positive. When the maximum revertant count does not exceed two to three times the 
spontaneous background rate, this rule concludes that the test is negative.  
 
A standard volume of 0.1ml test sample per plate was applied across all strains. The test sample 
(0.08g/ml) was prepared by dissolving lyophilised extract (0.57g) in 7ml distilled water. The 
following concentrations were tested: (i) 0.005, 0.02 and 0.08g/ml for A. oppositifolia, Pelargonium, 
P. aquilinum and R. lanceolatus; and (ii) 0.00125; 0.005 and 0.02g/ml for Z. aethiopica as a result 
of problems with viscosity. The working culture (1ml) of tester strains TA97a, TA98, TA100 and 
TA102 was seeded into sterile oxoid nutrient broth (50ml) and incubated at 37oC overnight on an 
orbital shaker. Top agar was supplemented with histidine/biotin (0.5mM) and maintained at 45oC in 
a waterbath. The working culture (0.1ml) was added to 2ml top agar, followed by plant extract 
(0.1ml) and 4% S9 mix (0.5ml) for the analysis of promutagens (chemicals requiring metabolic 
activation). The top agar was overlayed onto minimum glucose agar (MGA) plates and incubated 
at 37oC for 48hrs. For the positive control the plant extract was replaced with 2-AAF (in strains 
TA97a, TA98 and TA100, with S9) and cumene hydroperoxide (in strain TA102 without S9). The 
extracts were tested in the absence of S9 in a similar manner with the exception that 2.5ml top 
agar was used instead of 2ml.  
 
The condition of the background lawn is an indicator of toxicity: (i) presence of the background 
lawn in agar plates indicates non-toxicity of extracts (Reid et al, 2006) and (ii) when there is 
“thinning” or complete absence of the background lawn, this indicates the toxicity of the test 
chemical. A decrease in the number of revertant colonies to levels below the spontaneous 
reversion level may on occasion be seen together with thinning (Mortelmans and Zeiger, 2000). 
Occasionally, numerous small “pinpoint” non-revertant colonies are present on the plate that are 
histidine-dependent bacteria, have survived high chemical toxicity and are readily visible to the 













2.7.1 Statistical analyses 
The gamma test was performed on the mean quadruplicate values and Kruskal’s gamma 
coefficient (γ) was calculated. In the Salmonella reverse mutation assay the gamma statistic is very 
useful for measuring trends and determining significance. A positive γ statistic is indicative of an 
upward trend or positive dose-response relationship, while a negative γ statistic is indicative of a 
decreased response (due to toxicity). A p-value ≤0.01 is an indicator of significance and the trend 
is significant at the 1% level.   
 
2.8 Chromosomal aberration test 
Chromosomal aberrations in normal chromosome structure or number (e.g. aneuploidy, polyploidy) 
occur spontaneously or as a result of chemical or radiation treatment (Mateuca et al., 2006). 
Structural chromosomal aberrations in peripheral blood lymphocytes, as assessed by the 
chromosome aberration assay, have been used for over 30 years in occupational and 
environmental settings as a biomarker of the early effects of genotoxic carcinogens (Hagmar et al., 
2004). The chromosomal aberration test is a cytogenetic procedure for investigating the 
clastogenic effects of chemicals on mammalian cells. Peripheral blood lymphocytes are most 
frequently used owing to their easy availability. Normal circulating lymphocytes do not divide under 
routine culture conditions, but are stimulated to proliferate by phytohaemagglutinin (PHA).  
 
2.8.1 Cultures  
The culture method was adapted from Fonseca et al. (2000). The blood was collected by 
venupuncture into lithium heparin tubes (self-donated). Whole blood (0.3ml) was added to 5ml 
RPMI-1640 with L-glutamine (Invitrogen Corporation, Gibco) and phytohaemagglutinin (100µl, m-
form, Invitrogen Corporation, Gibco). Blood was cultured at 37oC in 20ml tubes for 48hrs. The 
treatment with aqueous extract was done at three concentrations, that is, 0.005, 0.02 and 0.08g/ml 
for A. oppositifolia, Pelargonium, P. aquilinum, R. lanceolatus respectively and at 0.00125; 0.005 
and 0.02g/ml for Z. aethiopica in duplicate at 37oC for 24hrs. One hour before culturing ended (i.e. 
23hrs), Colcemid (10µg/ml, Karyomax, Invitrogen Corporation) was added to a final culture 
concentration of 19.6µl/ml for metaphase arrest and incubated at 37oC for a further 1hr. Fixation 
was performed by standard cytological procedures. The cells were exposed to a hypotonic shock 
(10ml, warmed 75mM KCl solution) for 20min at 37oC. The cells were then fixed in 5ml acetic 
acid:methanol (1:5v/v). The fix washes were done four times before a small quantity of fix (0.2ml) 
was transferred to the cells. The cell suspension was then dropped from a height of 30cm onto 
cold pre-cooled glass slides (pre-washed with fix).The slides were air-dried, incubated at 59oC for 
1hr and stained with Giemsa:Buffer solution (1:10v/v, Giemsa, BDH and Buffer, pH6.86, +/- 0.05, 
at 20oC, Cameron Chemical Consultants). Slides were coded to ensure a blinded evaluation. As a 
positive control, the cells were treated with methylmethanosulphate (10mM, MMS dissolved in 













and carried out by the method recommended by Savage (2004). The in vitro tests were also 
carried out in the presence of the S9 fraction (4%) for 24hrs. The S9 mix was filtered through a 
0.45µm filter prior to use. As a positive control, the cells were treated with cyclophosphamide 
(2.5mM dissolved in water). 
 
2.9 DNA content (flow cytometry) 
Owing to the absence of metaphase spreads in the chromosomal aberration assay for 
Pelargonium and A. oppositifolia extracts, an investigation into cell cycle arrest was initiated.  
 
2.9.1 Cultures 
The blood was collected by venupuncture into lithium heparin tubes (self-donated). Whole blood 
(1.2ml) was added to RPMI-1640 (5ml, BioWhittaker, Lonza) and phytohaemagglutinin (100µl, m-
form, Invitrogen Corporation, Gibco). Blood was cultured at 37oC in 20ml tubes for 48hrs. The 
cultures were treated with 0.08g/ml Pelargonium and A. oppositifolia extracts (0.1ml) and 
incubated at 37oC for 24hrs. Untreated culture comprising whole blood (1.2ml) added to 5ml RPMI-
1640 (BioWhittaker, Lonza) and phytohaemagglutinin (100µl, m-form, Invitrogen Corporation, 
Gibco) was included as a control. The experiment was performed in duplicate and the in vitro tests 
were also carried out in the presence of the S9 fraction (4%) for 24hrs. 
 
The cells were washed twice with cold 1x PBS (10ml aliquot) and the red blood cells (RBCs) were 
lysed in RBC lysis buffer (15ml) at room temperature for 15min. Centrifugation was carried out at 
2200rpm for 5min at 5oC. The treatment with the RBC lysis buffer was repeated until the pellet was 
white to translucent in colour and barely visible. The white blood cells (WBCs) were washed twice 
with cold 1x PBS (10ml aliquots) and the WBCs were re-suspended in 1xPBS (1ml) and 
transferred to FACS analysis tubes (Falcon 352052, 5ml round bottom, 12 x 75mm non-pyrogenic, 
Becton Dickinson). An aliquot (50µl) from each sample was diluted (30x) by the addition of 1x PBS 
(1450µl) and counted on a haemocytometer, the WBC count ranged from 55 to 95 X104 cells/ml. 
The remaining 9950µl WBC suspension was centrifuged at 2200rpm for 5min at 5oC. The pellet 
was treated with 10µg/ml RNaseA (100µl) at 37oC for 15min to remove RNA that would interfere 
with DNA analysis.  
 
To determine viability, the 30x diluted WBC sample (10µl) was added to trypan blue (100µl) and 
PBS (90µl). This 1:20 dilution was placed on a hemocytometer slide and counted. The viability was 
≥95% for Pelargonium and A. oppositifolia treated cells with and without metabolic activation. 
 
2.9.2 Staining cells for FACS analysis 
Cells were stained with propidium iodide. The amount of propidium iodide taken up by the cell is 













solution (Appendix B) was added to the RNaseA treated white blood cells. Analysis was performed 




















































3.1 Salmonella reverse mutation assay  
3.1.1 The CYP P450 concentration from difference spectra 
 
Fig 18. CYP P450 activity of S9 was measured by difference spectra using a double beam 
Beckman spectrophotometer UV5260. The scan speed was 1nm/sec and UV Chart 50nm/IN. The 
baseline was run at a sensitivity of 0.1 and 0.5 as a trial, and the former was selected. From the 
above graph (i) the CYP P450 absorbance A450-490 is 97-21.5 = 75.5 and (ii) the correction of 
baseline is 9.4-18 = -8.6. These values were inserted into the formula in 2.3.4 and the CYP P450 
activity calculated was 0.7nmol/mg, which was within the recommended range (0.6-0.8nmol/mg) 














3.1.2 Dose-response and range-finding study 
The dose-response of tester strains to known mutagens indicates that the test system is functional 
and responsive to mutagens. This experiment doubled up as a range-finding study for a positive 
control concentration that produced a two- to fivefold increase over the spontaneous revertant 
laboratory control values. The 2-acetamidofluorine (2-AAF) concentration range varied for each of 
the strains TA97a, TA98 and TA100 to obtain a good monotonic dose-response. The mutagens 2-
AAF and cumene hydroperoxide (CHP) were prepared in DMSO (see Appendix A).  
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Fig 19. Dose response of strain TA97a to increasing concentrations of 2-AAF. The plot of the 
means of quadruplicate values against increasing concentrations of mutagen is indicated above. 
 
The monotonic dose-response was observed for all strains over the concentration range tested. 
For TA97a (Fig 19) a positive control of 20µg/0.1ml 2-AAF was suitable because it produced a 
twofold increase in the number of revertant colonies (482) when compared to the spontaneous 
reversion laboratory control values (220±28) in Table 6. In order to establish whether a monotonic 
dose-response was present across the concentration range tested, the spontaneous reversion 
laboratory control values could not be plotted onto the graph but can be found in Table 6. For TA98 
(Fig 20), it can be seen that a positive control of 1.5µg/0.1ml 2-AAF was suitable because it 
produced a fivefold increase in the number of revertant colonies (216) when compared to the 
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Fig 20. Dose response of strain TA98 to increasing concentrations of 2-AAF  
The number of spontaneous revertants increased over the concentration range tested. 
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A positive control of 9µg/0.1ml 2-AAF was selected for TA100 (Fig 21) because it produced a 
twofold increase in the number of revertant colonies (403) when compared to the spontaneous 
reversion laboratory control values (187±14). 
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Fig 22. Dose response of tester strain TA102 to increasing concentrations of CHP, a directly acting 
mutagen  
 
A positive control of 110µg/0.1ml CHP was selected for TA102 (Fig 22) because it produced a 
twofold increase in the number of revertant colonies (1103) when compared to the spontaneous 
reversion laboratory control values (564±78). The results of the range-finding study is summarised 
in Table 7. 
 





TA97a 20µg/0.1ml - 
TA98 1.5µg/0.1ml - 
TA100 9µg/0.1ml - 
TA102 - 110µg/0.1ml 
 
3.1.3 Salmonella reverse mutation assay  
Chemicals are judged to be non-mutagenic when they have been tested in at least four Salmonella 
tester strains: a positive response in any single strain either with or without metabolic activation is 
sufficient for designating a chemical as a mutagen and often causes the substance to be branded 
a presumptive carcinogen until definitive results have been obtained from a two-year 













statistics are very useful for measuring trends and significance. A positive gamma statistic is 
indicative of an upward trend and a positive dose response relationship. A negative gamma 
statistic is indicative of a decreased response possibly due to (i) toxicity, which may be associated 
with thinning or complete absence of the background lawn, or (ii) antibacterial activity in the test 
substance. Plant extracts were prepared as described in Chapter 2 on materials and method. It is 
important to note that the aqueous extracts were prepared from the aerial part of the plant (leaves), 
and are most often consumed in this manner as medicine and dietary supplements. The data, 
including standard deviation and statistical significance, are tabulated in Tables 8 and 9. 
 
3.1.4 Acokanthera oppositifolia (Lam.) and Zantedeschia aethiopica (L.)  
A. oppositifolia and Z. aethiopica proved to be non-mutagenic with all four tester strains with or 
without S9. Although Z. Aethiopica was non-mutagenic, it produced a significant decrease in the 
number of revertants in TA97a with S9 (p≤0.01). Visual inspection of the plates showed an intact 
background lawn with small pinpoint colonies, easily mistaken for revertant colonies. This indicated 
that Z. aethiopica was toxic but only in the presence of S9. Calcium oxalate, a chemical constituent 
of Z. aethiopica, is known to produce toxicity. The leaves of Z. aethiopica have a unique mannose-
binding lectin that binds to cell membranes that are often toxic (van Wyk et al., 1997 and Chen et 
al., 2004). One can speculate that the toxicity in TA97a with S9 may be attributed to (i) metabolic 
intermediates of calcium oxalate and lectins or (ii) phytochemical metabolites of Z. aethiopica that 
may have potential antibacterial activity. What is rather alarming is that only one tester strain was 
affected in this manner when all strains carry the rfa deletion, making their cell wall more 
permeable to the penetration of chemicals. Since it is generally accepted that mutagenicity in any 
one of the tester strains with or without S9 is a positive response, based on a similar principle, 
toxicity in any one of the tester strains with or without S9 should be sufficient to brand the chemical 
as a potential toxicant. 
 
3.1.5 Pelargonium sp. cf. inquinans ( L.) L’ Herit  
The results indicate that (i) in TA102 (Fig 23B) phytochemicals in the Pelargonium extract were 
mutagenic by one or more of the following mechanisms: transition and transversion reactions, DNA 
crosslinkage and oxidative DNA damage and (ii) in TA97a (Fig 23A) the cytoxicity of the 
Pelargonium extract in the presence of S9 is undoubtedly due to a phytochemical metabolite.  
 
Furthermore, phytochemical metabolites of Pelargonium may have potential antibacterial activity. 
Coumarin, a chemical constituent of Pelargonium sp, may contribute to the cytotoxicity observed at 
increasing concentrations. With regards to a potential risk related to the coumarin content, a NOEL  
(no observed effect level) value of more than 750mg/kg body weight has been established in dogs 

















































 A             Number of revertants per plate versus extract 
with strain TA97a+ S9
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B            Number of revertants per plate versus extract 
with strain TA102
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Fig 23. Salmonella reverse mutation assay of Pelargonium sp. (A). The significant downward trend 
at a level of 1% (p≤0.01) with TA97a in the presence of S9 was observed. (B) The upward trend 
observed for PL in TA102 in the absence of S9 is significant (p≤0.01), indicating strong 
mutagenicity. 
 
P. sidoides root extracts have a track record of success as a plant-based medicine and the plant is 
currently commercialised as EPs®7630 (Umckaloabo) (refer to Table 2 for its beneficial effects). In 
general, Pelargonium sp is used for the manufacture of rose-scented geranium oil that is used 
mainly in aromatherapy and in the fragrance industry. Traditionally, the leaves and root of 
Pelargonium sp are taken as tea or for the treatment of medical ailments such as dysentery and 













3.1.6 Pteridium aquilinum subsp aquilinum 
A        Number of revertants per plate versus extract 
with TA 100 + S9
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B       Number of revertants per plate versus extract
with TA 102
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Fig 24. Salmonella reverse mutation assay of P. aquilinum indicates a mutagenic reaction with two 
of the four tester strains (p≤0.01) (A) in TA100 with S9 metabolic activation and (B) TA102 in the 
absence of S9.  
 
P. aquilinum is mutagenic with (i) TA100 in the presence of S9 and (ii) TA102 in the absence of S9, 
which is evidence of promutagens and mutagens respectively. The mutagenicity, clastogenicity, 
teratogenicity and carcinogenicity of the major bracken carcinogen, ptaquiloside, a 
norsesquiterpene glucoside, has been convincingly demonstrated. Ptaquiloside is quite unstable 













loss of the glucose moiety into pteridienone, which has been found to have more pronounced 
activity over ptaquiloside (Matsuoka et al., 1989). 
 
The decomposition of ptaquiloside is pH dependent, and studies have shown that ptaquiloside and 
its related compounds produce mutagenicity in the Salmonella reverse mutation assay in TA98 and 
TA100 under weakly basic conditions (pH8.5) (Nagao et al., 1989). However, the pH in the current 
experiment was not controlled and mutagenicity was produced in (i) TA100 by base-pair 
substitution exerted by metabolic intermediates and (ii) in TA102 possibly by the crosslinkage 
reactions of ptaquiloside and pteridienone with DNA. These compounds have a strong alkylating 
capacity and react with DNA. 
 
3.1.7 Rumex lanceolatus Thunb.  
This extract contains compounds that are potent mutagens and promutagens, as detected with all 
four tester strains with and without metabolic activation (Fig 25). The mechanisms of DNA damage 
are by frameshift mutations, base-pair substitution, transition and transversion mutations, DNA 
crosslinkage and oxidative DNA damage. 
 
Rumex species are related to the well-known medicinal plants known as rhubarbs (Rheum 
species) (van Wyk and Wink, 2004). Several monomeric anthraquinones, such as emodin (1,3,8-
trihydroxy-6-methyl-anthraquinone) and related derivatives that are constituents of rhubarb (an 
oriental medicine for diarrhoea) exhibit mutagenicity in the Salmonella/microsomes test and 
cultured tumour cells (Morita et al., 1988 and Ueno, 1991). Emodin is a constituent of R. 
lanceolatus (Watt and Breyer-Brandwijk, 1962), which may be responsible for the potent mutagenic 
response observed. 
 
3.2 Chromosomal aberration test 
The in vitro chromosomal aberration test was used to measure the clastogenicity of aqueous plant 
extracts in peripheral blood lymphocytes. The chromosomal aberration test was done in duplicate 
with S9 activation and non-activation at three concentrations of plant extract: (i) concentrations of 
0.005, 0.02 and 0.08g/ml P. aquilinum and R. lanceolatus and (ii) concentrations of 0.00125; 0.005 
and 0.02g/ml for Z. aethiopica because of problems with viscosity. The positive control used in the 
non-activation analysis was methanemethanosulphate (MMS), soluble in 0.5% DMSO for which a 
solvent control was included. The positive control used with S9 activation was cyclophosphamide 
(CPA), which is water soluble. Chromosomal aberrations were scored from metaphase arrested 
cells that had been fixed, dropped from a height of 30cm onto microscope slides and Giemsa 
stained. However, this method is not suitable for estimating numerical chromosomal aberrations, 
as artefactual chromosome loss may occur (Mateuca et al., 2006) and its use for this purpose was 


























printer) facilitated image capture via a microscope mounted video camera, digitisation of the 
captured image, storage on the computer’s hard disk or on compact disc (CD) as a 
photomicrograph to be imported or printed. 
 
Extensive research has been done by means of light microscopy from which categories of 
structural chromosome aberrations for metaphase cells have been established (Fig 13). 
Metaphase cells were scored as recommended by Savage (2004) and categorised into 
chromosome-type (CSA) and chromatid-type (CTA) aberrations. The CSA and CTA types arise 
from cell cycle progression (G1, S, G2 and M) and in relation to S-phase independent or dependent 
clastogens. CSAs result from incompletely repaired or unrepaired double-strand breaks mostly 
generated in vivo in Go–G1 lymphocytes by S-phase independent clastogens (e.g. ionising 
radiation). After DNA synthesis and chromosome duplication, the aberrations formed in Go–G1 
were doubled and chromosome-type breaks were seen in metaphase. CTAs (e.g. chromatid type 
breaks) arose predominantly in vitro during the G2-phase or late S-phase of the cultured 
lymphocytes in response to base modifications and single-strand breaks (SSBs) induced by S-
phase-dependent clastogens (e.g. chemicals) (Savage 1975, 2004; Albertini et al., 2000, Hagmar 
et al., 2004 and Mateuca et al., 2006). 
 
3.2.1 Pteridium aquilinum subsp aquilinum 
This test was done in duplicate and the average values from scoring approximately 50 metaphases 
was tabulated (Table 10). Photomicrographs depict chromatid-type aberrations (CTAs) observed at 
metaphase in Fig 26a, b and c. A chromatid aberration results from a single strand DNA break 
(SSB) occurring in the G2 phase of the cell cycle by S-phase dependent clastogens in the 0.005 
and 0.02g/ml P. aquilinum extracts.  
 
The clastogenicity is attributed to ptaquiloside and pteridienone. Liver enzymes and CYP P450 
play a major role in the detoxification of drugs and xenobiotics in the body. This was observed by a 
reduction of aberrations to 2% in P. aquilinum treated cultures with S9 under the current in vitro 
experimental conditions. The clastogenicity decreased in the presence of S9 as a result of 
detoxification; however, metabolically activated clastogens were still evident. A graphical 
























Fig 26a.  A chromatid gap after treatment of peripheral blood lymphocytes with 0.005g/ml P. 







% cells with chromatid 
aberrations (CTAs) 
% cells with chromosome 
aberrations (CSAs) 
Gaps Breaks Gaps Breaks 
Nonactivation      
P. aquilinum 0.005 10 2 6 0 
 0.02 5 0 5 3 
 0.08 3 3 0 5 
Negative control 
(untreated blood) 
- 0 0 0 0 
0.5% DMSO  2 4 2 2 
10mM MMS  14 4 6 6 
      
S9 activation (24 hr 
exposure) 
     
P. aquilinum 0.005 0 2 2 0 
 0.02 2 2 0 0 
 0.08 0 0 0 0 
Negative control 
(untreated blood) 
 0 0 0 0 














Fig 26b. Chromatid break caused after treatment of lymphocytes with 0.005g/ml P. aquilinum with 
S9. A reduction in chromosomal aberrations was observed after metabolic activation with S9 owing 
to detoxification reactions [Slide ZD12, vernier 61 X 93.5, aberration ZD12.5] 
 
 
Fig 26c Chromatid break caused by treatment of lymphocytes with 0.02g/ml P. aquilinum with S9 



























































0.005g/ml 0.02g/ml 0.08g/ml Control (-) 2.5mM CPA























Fig 27. The treatment of lymphocytes with P aquilinum at three increasing concentrations, 0.005; 
0.02 and 0.08g/ml, in (A) the absence of S9 and (B) presence of S9. The reduction in genotoxicity 
is evident with CYP P450 and liver enzymes. The 10mM methylmethanosuphate (MMS) is soluble 
in 0.5% DMSO and cyclophosphamide (CPA) is water soluble. 
 
3.2.2 Rumex lanceolatus Thunb. 
This test was done in duplicate and the average values from scoring approximately 50 metaphases 
was tabulated (Table 11). R. lanceolatus generated CTAs (Fig 28) and CSAs at 0.005, 0.02 and 
0.08g/ml without S9. However, only CSAs were generated at 0.005 and 0.02g/ml in the presence 













cells with aberrations decreased in the presence of S9 as a result of phase II enzymes that 
deactivate the reactive species. However, the chromosome breaks evident at 0.005 and 0.02g/ml 
in the presence of S9 are attributed to S-phase independent clastogenic metabolites, possibly 2-
hydroxy-emodin. 
 
Fig 28. A chromatid gap by treatment of lymphocytes with 0.02g/ml R. lanceolatus without S9, 
indicating direct genotoxicity. The CTA was generated at the G2 phase of the cell cycle by S-phase 
dependent phytochemical clastogens in the R. lanceolatus extract [Slide Z5, vernier 61 X 103, 
aberration Z5.1]. 
 




% cells with chromatid 
aberrations (CTAs) 
% cells with chromosome 
aberrations (CSAs) 
Gaps Breaks Gaps Breaks 
Nonactivation      
R. lanceolatus 0.005 6 0 0 0 
 0.02 6 2 0 4 
 0.08 0 2 0 4 
Negative control 
(untreated blood) 
- 0 0 0 0 
0.5% DMSO  2 4 2 2 
10mM MMS  14 4 6 6 
      
S9 activation (24hr 
exposure) 
     
R. lanceolatus 0.005 0 0 0 2 
 0.02 0 0 0 2 
 0.08 0 0 0 0 
Negative control 
(untreated blood) 
 0 0 0 0 
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Fig 29. The treatment of lymphocytes with R lanceolatus at three increasing concentrations 0.005, 
0.02 and 0.08g/ml in (A) the absence of S9 and (B) the presence of S9 where the chromosomal 















3.2.3 Zantedeschia aethiopica (L.) 
 
Fig 30a. Chromosome gap caused by treatment of lymphocytes with 0.005g/ml Z. aethiopica in the 
absence of S9 [slide X2, vernier73 X 93, aberration X2.1] 
 
 
Fig 30b. Chromatid break caused by treatment with 0.005g/ml Z aethiopica in the absence of S9 

















% cells with chromatid 
aberrations (CTAs) 
% cells with chromosome 
aberrations (CSAs) 
Gaps Breaks Gaps Breaks 
Nonactivation      
Z. aethiopica 0.00125 0 0 0 0 
 0.005 2 2 1 0 
 0.02 2 4 2 0 
Negative control 
(untreated blood) 
- 0 0 0 0 
0.5% DMSO  2 4 2 2 
10mM MMS  14 4 6 6 
      
S9 activation (24hr 
exposure) 
     
Z. aethiopica 0.00125 0 0 0 0 
 0.005 0 0 0 0 
 0.02 0 4 0 0 
Negative control 
(untreated blood) 
 0 0 0 0 
2.5mM CPA  15 10 3 3 
 
The chromosome-type aberrations (CSA) seen in Fig 30a above were generated in the Go-G1 
phase of the cell cycle from an S-phase independent phytochemical clastogen. The chromatid-type 
aberration (CTA) seen in Fig 30b above was generated in S or G2 of the cell cycle from an S-phase 
dependent phytochemical clastogen. CTAs and CSAs were generated over the concentration 
range tested, but were reduced in the presence of S9 (Fig 31a,b). 










0.00125g/ml 0.005g/ml 0.02g/ml Control (-) 0.5% DMSO 10mM MMS























Fig 31a. A dose related increase in chromatid breaks and chromosome gaps was observed with 
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Fig 31b. A reduction in genotoxicity in the presence of S9 was observed for Z. aethiopica 
 
3.3 Flow cytometry (DNA content) 
A. oppositifolia and Pelargonium inhibited mitosis in the chromosomal aberration test and produced 
no scorable metaphases. Cell cycle arrest was investigated by flow cytometry. Experiments for 
DNA content were carried out in duplicate at the highest concentration, 0.08g/ml. Since 
lymphocytes are quiescent (i.e. in Go phase they are not actively dividing cells), the cultures were 
stimulated with phytohaemagglutinin (PHA) to enter the cell cycle (G1, S, G2-M). After 72hrs at 
37oC, the red blood cells were lysed and the DNA content of the white blood cells was determined 
by flow cytometry. In both treated and untreated cells, ≥95% viable white blood cells remained at 
the end of the 24hr treatment period. Three distinct populations of white blood cells based on their 
difference in size lymphocytes<monocytes<granulocytes were visualised. The instrument was 
configured to measure the DNA content of lymphocytes and the data tabulated in Table 13.  
 








Microculture PHA %Go-G1 %S %G2-M 
Blood + PHA (control) 100µl 81±1 19±1 0.1±0 
A. oppositifolia 0.08g/ml, -S9 100µl 86±0 14±0 0 
A. oppositifolia 0.08g/ml, +S9 100µl 99±1 2±1 0 
Pelargonium 0.08g/ml, -S9 100µl 98±1 2±1 0 













The control (blood + PHA) produced 0.1% G2-M phase cells which was lower than expected (i) due 
to the fact that lymphocytes are at a much lower concentration in the blood when compared to 
monocytes and granulocytes; (ii) since lymphocytes are extremely small they were lost during 
centrifugation at 1500rpm for 5min (recommended for cell lines), which was modified to 2200rpm 
for 5min at 5oC, but some loss of cells was still experienced; and (iii) because the propidium iodide 
stain was taken up by all the white blood cells; it did not differentiate the monocytes, granulocytes 
and lymphocytes and the separation was reliant on size.  
 
The studies of DNA content confirmed an increase in the percentage of the Go-G1 phase of the cell 
cycle in A. oppositifolia and Pelargonium treated cells with a concomitant decrease in the 
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Fig 32. DNA content of lymphocytes from A. oppositifolia and Pelargonium sp treatment with and 
without S9. The G2-M phase of the cell cycle was absent in all treatment groups with the exception 
of the control (blood + PHA) which had 0.1% G2-M phase.  
 
was evident for any of the treated cells. This indicates a Go/G1 blockage in the cell cycle and is the 
reason for the absence of G2/M phase. A. oppositifolia with S9 produced a greater Go/G1 blockage 













metabolites of A. oppositifolia are more potent cell cycle arresting substances. Pelargonium without 
S9 produced a greater Go/G1 blockage (98±1) when compared to with S9 (89±1), indicating that 
phytochemicals in the extract are potential cell cycle arresting substances. These plants should be 
further investigated for their cancer chemopreventative properties. The studies of DNA content in 
A. oppositifolia and Pelargonium confirmed the absence of the G2-M phase of the cell cycle, 
















































The Salmonella reverse mutation assay was used as a primary screen for measuring the ability of 
plant extracts or metabolites to induce DNA mutations. The extract was judged to be non-
mutagenic when tested in at least four Salmonella tester strains. A positive response in any single 
strain either with or without metabolic activation is considered sufficient for designating the extract 
as a mutagen and a presumptive carcinogen until definitive carcinogenicity studies are performed. 
The Salmonella reverse mutation assay identifies chemicals that react with cellular DNA to 
produce mutations, whereas the carcinogenicity test identifies only those chemicals that can 
induce tumour cells that survive and replicate to form visible tumours.  
 
Structural chromosomal aberrations in the form of gaps and breaks were detected in metaphase 
cells and comprise both chromosome aberrations (CSAs) and chromatid aberrations (CTAs). 
These aberrations arise from cell cycle progression and in relation to S-phase-independent or 
dependent clastogens as follows: CSAs result from incompletely repaired or unrepaired double-
strand breaks mostly generated in vivo in Go–G1 lymphocytes by S-phase-independent clastogens 
(e.g. ionising radiation) (Mateuca et al., 2006). After DNA synthesis and chromosome duplication, 
the aberrations formed in Go–G1 are replicated and chromosome-type breaks (CSAs) are seen in 
metaphase, chromatid-type breaks (CTAs) arise predominantly in vitro during the G2 or late S-
phase of the cultured lymphocytes in response to base modifications and single-strand breaks 
(SSBs) induced by S-phase-dependent clastogens (e.g. chemicals) (Albertini et al., 2000 and 
Hagmar et al., 2004).  
 
Evidence from a recent study conducted by Norppa et al. (2006) indicates that both chromatid-type 
and chromosome-type aberrations predict cancer, even though some data suggest that 
chromosome-type aberrations may have a more pronounced predictive value than chromatid-type 
aberrations. The relationship between the presence of a high frequency of chromosome 
aberrations and a predisposition to cancer has been well established in chromosome instability 
syndromes (e.g. ataxia telangiectasia, Fanconi’s anaemia and Bloom’s syndrome) (Barrios et al., 
1991). Furthermore, structural and numerical chromosome aberrations are evident in bladder 
carcinomas (gaps or breaks = 25.37%, major structural chromosome abnormalities = 67.16% and 
numerical chromosome aberrations = 7.46%) (Barrios et al., 1990).  
 
Although peripheral blood lymphocytes are frequently used in the chromosomal aberration assay, 
the use of whole blood cultures has many disadvantages. The initial concentration of the different 
cell types in whole blood is unknown at the time of seeding. Red blood cells cause interference 













the concentration of lymphocytes. In a “whole blood culture environment”, there is potential 
interference between blood components and the extract. In addition, the donor’s genetic 
predisposition to chromosomal aberration frequency will impact on the results. However, although 
this was not controlled in the current experiment, it is recommended that the test be performed with 
blood from different donors. Supporting evidence comes from studies showing a decrease in 
chromosomal aberration frequency in individuals with homozygous genotype for the XPD 751Gln 
variant allele (Vodicka et al, 2004 and Mateuca, 2006). Therefore, an individual’s susceptibility to 
chromosomal aberrations may impact on the test, as peripheral blood lymphocytes from such 
individuals will be “resilient” to genotoxic agents. Since a high frequency of structural chromosomal 
aberrations in lymphocytes is predictive of increased cancer risk, it is advisable to use blood from 
more than one source for the chromosomal aberration test to circumvent the problem encountered 
with genetic resilience. Cell lines, such as Chinese hamster ovary cells, which were used for the 
detection of clastogenicity in Aristolochia sp. (Zhang et al., 2004) would have averted the many 
problems encountered. The lack of automated systems for colony counting in the Salmonella 
reverse mutation assay and scoring metaphase cells in the chromosomal aberration test presented 
difficulty. The results of the mutagenicity and clastogenicity studies under the current experimental 
conditions are discussed in the following sections. 
 
4.1 R. lanceolatus 
The aqueous extract prepared from the aerial parts of R. lanceolatus contains potent mutagens 
and pro-mutagens. Mutagenicity was detected with all four tester strains TA97a, TA98, TA100 and 
TA102 in the presence and absence of S9 (p≤0.01). Metabolic activation produces strong 
electrophiles that have a high affinity for DNA, resulting in DNA damage. The phytochemicals and 
metabolites of R. lanceolatus cause DNA damage through a variety of mechanisms: (i) frameshift 
mutations detected by TA97a and TA98; (ii) base-pair substitutions detected by TA100; and (iii) 
oxidative DNA damage, transition and transversion reactions (Fig 33) and cross-linking reactions 
detected by TA102. The compounds present in the R. lanceolatus extract are presumptive rodent 
carcinogens (and potential human carcinogens).  
 
Emodin, a monomeric anthraquinone constituent of R. lanceolatus (Watt and Breyer-Brandwijk, 
1962), may be responsible for the mutagenicity observed in TA97a, TA98, TA100 and TA102 in 
this study. Supporting evidence comes from extensive studies conducted in the 1980s, which show 
that many monomeric anthraquinones, such as emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) 
and related derivatives that are constituents of Rheum (rhubarb), exhibit mutagenicity in the 
Salmonella reversion/microsome tests and cultured tumour cells (Morita et al., 1988 and Ueno, 
1991). The genus Rumex (sorrel, dock) and Rheum belong to the same family, Polygonaceae. 













microsomes (Masuda and Ueno, 1983 and Masuda et al., 1985). CYP P450 catalyses this 
biotransformation (Ueno 1985 and Masuda et al., 1985). 
 
Fig 33. Base substitution reactions by transitions and transversion. Transitions are interchanges of 
purines (A G) or pyrimdines (C T); they therefore involve bases of similar shape. Transversions 
are interchanges between purine and pyrimidine bases, which involve the exchange of one-ring 
and two-ring structures. 
 
2-Hydroxy-emodin has a strong electron-spin resonance in a mixture with DNA, which indicates the 
participation of free radicals derived from anthraquinone in DNA damage (Kodama et al., 1987) 
and may account for the oxidative DNA damage observed with TA102 in the current investigation. 
Since hydroxy-radical-forming agents selectively hydroxylate deoxyguanosine residues of DNA at 
C-8 in in vivo and in vitro systems, it was presumed that the anthraquinones cause genotoxicity by 
their potential for hydroxy radical formation (Hayatsu, 1990). These anthraquinones show 
characteristic colours in solutions and on TLC (thin layer chromatography) plates and this physical 
property is applied for identification and quantitation in TLC (Ueno, 1982). Furthermore, dimeric 
anthraquinones, such as luteoskyrin and rugulosin, are hepatotoxic and hepatocarcinogenic in 
mice (Uraguchi et al., 1972 and Ueno et al., 1980).  
 
In the chromosomal aberration test, R. lanceolatus extract produced CTAs and CSAs over the 
concentration range tested in the presence and absence of S9; however there was a reduction of 













occur at Go/G1 and CSAs at G2 or the late S-phase of the cell cycle, R. lanceolatus extract has 
both S-phase-dependent and independent clastogens. The study by Schwartz (1989) indicates 
that alkylating agents are S-phase-dependent clastogenic agents, that is, chromosomal aberrations 
are not observed unless the treated cells have first undergone a round of replicative DNA 
synthesis. It can be speculated that CTAs were generated by S-phase-independent chemical 
compounds originating in the extract or from metabolism. A decreased percentage of cells with 
aberrations in the presence of S9 indicated the detoxification of clastogenic phytochemicals by 
CYP P450. In the presence of S9, the 2% CSAs produced at 0.005g/ml and 0.02g/ml is due 
probably to S-phase-dependent clastogenic metabolites, possibly 2-hydroxy-emodin. Supporting 
evidence comes from the fact that 2-hydroxy-emodin caused strand breaks in circular phage DNA 
(Kodama et al., 1987) and may be the cause of the clastogenicity observed in the presence of S9 
at 0.005 and 0.02g/ml. However, in light of the results from the study by Lee et al. (2005), which 
demonstrated that emodin from the aerial parts of Rumex acetosa inhibited the proliferation of 
tumour cells, was antimutagenic and antigenotoxic, the R. lanceolatus extract tested requires 
further investigation. 
 
The beneficial effects of Rumex induratus as a good dietary source of nutrients owing to its 
agreeable taste, and a high phenolic content cannot be ruled out; however, it has to be 
approached with caution owing to its high oxalic acid content. No high doses can be consumed 
because oxalic acid has a predicted LD50 value (the mg/kg dose required to kill 50% of a test 
population) of 375mg/kg body weight (Ferreres et al., 2006). 
 
Other effects of Rumex sp. are anti-fertility action (R. steudelii), antibacterial and anti-inflammatory 
activities (Rumex nervosus and Rumex abyssinicus), antidiarrheal effects (Rumex maritimus) and 
antiviral activities (Rumex bequaerti) (Getie et al., 2002; Rouf et al., 2002; Cos et al., 2002 and 
Gebrie et al., 2004). The lessons from the “Aristolochia incident” in the early 1980s indicate that 
mutagenicity tests, such as the Salmonella reverse mutation assay and chromosomal aberration, 
are good indicators of potential carcinogenicity. Extracts of R. lanceolatus have produced both 
mutagenic and clastogenic effects under the current experimental conditions and must be further 
investigated. 
  
4.2 Pelargonium sp.  
Perlargonium extract proved to be mutagenic with TA102 in the absence of S9 (p≤0.01), 
implicating directly acting mutagens in DNA damage by any of the following: transition/transversion 
reactions, oxidative DNA damage or cross-linking reactions. Perlargonium is known to contain 














reactivation of UV-irradiated phage T1 in E coli (Grigg, 1972). TA102 has an intact excision repair 
system unlike the other three Salmonella tester strains, TA7a, TA98 and TA100, which may have 
been targeted by coumarin in the Perlargonium extract. Toxicity was observed at a level of 1% 
(p≤0.01) with TA97a in the presence of S9, and was attributed to a metabolically activated 
phytochemical. Alternatively, this effect may have arisen from antibacterial activity since 
isoquercetrin and rutin, respective major and minor flavonoids obtained from Pelargonium radula 
(Cav.) L’Herit, were shown to have antimicrobial activity (Pepeljnjak et al., 2005). Under the current 
experimental conditions Pelargonium is a presumptive carcinogen (mutagenic with TA102), and 
showed in vitro cytotoxicity and/or antibacterial activity. 
 
Rose-scented geranium oil from Pelargonium sp. is of high value in the fragrance industry, while P 
sidoides root extract commercialised as EPs®7630 (Umckaloabo) has several benefits (refer to 
Table 2). In a Pelargonium sidoides related toxicological study on potential risk related to the 
coumarin content, a NOEL (no observed effect level) value of more than 750mg/kg body weight 
was established in dogs and rats (Brendler et al., 2008). NOEL values are generated from the 
dose-response curves of various agents by plotting “percent of population affected versus dose 
(mg/kg)”. When examining such graphs, there is often a minimum concentration (or threshold) of 
dose below which there is no observable effect in the test population (e.g. dogs, rats) and this is 
referred to as the NOEL. The NOEL dose information obtained from animal experimentation is 
often used to establish safe levels for humans. Similar toxicological studies are warranted for use 
of Pelargonium as a traditional medicine in South Africa due to the toxicity observed with TA97a.  
 
In the chromosomal aberration test, Pelargonium caused cell-cycle inhibition of peripheral blood 
lymphocytes. The studies of DNA content in Pelargonium confirmed the absence of G2-M phase of 
the cell cycle, indicating a blockage in the Go/G1 phase of the cell cycle, therefore the clastogenicity 
of this extract should be investigated with other test methods. Since the aqueous extract of the 
aerial parts of this plant caused cell-cycle inhibition further studies for its potential as a cancer 
chemotherapeutic agent should be undertaken. 
 
4.3 P. aquilinum 
P. aquilinum produced highly significant mutagenicity with TA102 in the absence of S9 (p≤0.01), 
implicating directly acting mutagens in DNA damage by any of the following mechanisms: 
transition/transversion reactions (Fig 33), oxidative DNA damage and cross-linking reactions. 
Furthermore P. aquilinum proved to be mutagenic with TA100 in the presence of S9 (p≤0.01), 
implicating pro-mutagens in DNA damage by means of a mechanism of base-pair substitution. The 
toxicity observed in TA97a with S9 was significant (p≤0.01), and since this toxicity was not evident 














The experimental results for P. aquilinum (bracken fern) indicate both mutagenic and promutagenic 
activity. Ptaquiloside is responsible for adenine to pyrimidine transversion in the H-ras gene on 
codon 61 (N3 position) (Alonso-Amelot and Avendano, 2002), and therefore it is conceivable that 
ptaquiloside carries out mutagenicity by purine to pyrimidine transversions in TA102 or by cross-
linkage reactions, since both ptaquiloside and pteridienone in bracken fern are alkylating agents. 
Pteridienone was found to have more pronounced alkylating activity over ptaquiloside (Matsuoka et 
al., 1989). Other chemical constituents of bracken fern, hypolosides and illudins M and S, 
produced mutagenicity in the Salmonella reversion test with TA98 and TA100 (Nagao et al., 1989). 
 
It was found that P. aquilinum generated CTAs and CSAs in the presence and absence of S9. 
Schwartz (1989) reported that alkylating agents are S-phase-dependent clastogenic agents, that is, 
chromosomal aberrations are not observed unless the treated cells have first undergone a 
replicative DNA synthesis. Therefore, CSAs must be attributed to ptaquiloside and pteridienone, 
which are alkylating agents. In the presence of S9 the aberrations were reduced by CYP P450 
detoxification; however, metabolically activated S-phase-independent clastogens are still evident. 
Supporting evidence comes from the structural chromosomal aberrations produced in the 
peritoneal cells of female Swiss mice treated with a variety of bracken fern extracts, including hot 
and cold water extracts (Almeida Santos et al., 2006). Hypoloside B and C are clastogenic at a 
dose of 4.5µg/ml, and illudin M and S are potent clastogens and induced aberrations at much 
lower doses than ptaquiloside (Matsuoka et al., 1989). The clastogenicity, mutagenicity, 
carcinogenicity and teratogenicity of P. aquilinum has been convincingly demonstrated in prior 
studies (Kofod and Eyjolfsson, 1966; Kamon and Hiryama, 1975; Hirayama, 1979; Hirono et al., 
1984a,1984b; Reddy and Randerath, 1987; Kellerman et al., 1988; Matsuoka et al., 1989; Sato et 
al., 1991; Shahin et al., 1998; Marliere et al., 1998, 2000; Alonso-Amelot and Avendano, 2002 and 
Almeida Santos et al., 2006). There is a potential risk for the development of cancer of the upper 
alimentary tract if this plant is ingested. 
 
4.4 A. oppositifolia 
A. oppositifolia proved to be non-mutagenic with all four Salmonella tester strains (TA97a, TA98, 
TA100 and TA102) in the presence and absence of S9. In a study conducted by Wangenheim and 
Bolcsfoldi (1988), ouabain proved to be mutagenic in a mouse lymphoma assay, however the 
quantity of ouabain varies in Acokanthera sp.; it is present in trace amounts or completely absent 
in the South African A. oppositifolia (Neuwinger, 1996), explaining the non-mutagenicity observed 
in the current study. 
 
The clastogenicity of A. oppositifolia was not established owing to the cell-cycle inhibition of 
peripheral blood lymphocytes in the chromosomal aberration test. The studies of DNA content in A. 












Go/G1 phase of the cell cycle, therefore the clastogenicity of this extract should be investigated with 
other test methods.  
 
Since the South African A. oppositifolia contains trace amounts of ouabain (or completely absent); 
the water-soluble acolongifloriside K showed no in vivo activity in the study conducted by 
Wangenheim and Bolcsfoldi (1988); the aqueous extract of the aerial parts of this plant is non-
mutagenic and inhibits mitosis as observed in the current study, this plant extract is a good 
candidate for further studies into its cancer chemotherapeutic value. 
 
4.5 Z. aethiopica 
Z. aethiopica proved to be non-mutagenic with all four strains in the presence and absence of S9. 
Z. aethiopica was toxic with TA97a in the presence of S9 and the trend was significant at the 1% 
level (p≤0.01). Since this toxicity was not evident in the absence of S9, it was attributed to a 
chemical that was metabolically activated. Z. aethiopica was clastogenic and produced CTAs and 
CSAs which were reduced in the presence of S9; however, metabolically activated S-phase-
dependent clastogens, giving rise to a level of 2% chromatid breaks, were still evident with S9. 
 
Z. aethiopica has characteristic lectins that have the ability to bind to cell membranes, which 
probably accounts for the precipitation or agglutination of red blood cells observed in the cultures. 
Further toxicological studies are required since toxicity was observed with TA97a. 
 
4.6 Conclusion and future prospects 
It was found that R. lanceolatus and P. aquilinum are mutagenic in the Salmonella reverse 
mutation assay in the presence and absence of metabolic activation (p≤0.01), with R. lanceolatus 
showing the highest dose-response. Pelargonium, meanwhile, was found to be mutagenic in the 
absence of metabolic activation (p≤0.01). Definitive carcinogenicity studies should be conducted 
on these three extracts, since a positive response in any single strain, either with or without 
metabolic activation, is considered sufficient for designating the extract a mutagen and a 
presumptive carcinogen. In vitro cytoxicity was observed for Z. aethiopica and Pelargonium with 
TA97a in the presence of metabolic activation (S9), therefore toxicology studies would seem to be 
indicated. R. lanceolatus, P. aquilinum and Z. aethiopica were all found to be clastogenic in the 
chromosomal aberration test with peripheral blood lymphocytes in the presence and absence of 
S9; however, a reduction in the number of aberrations was observed in the presence of S9 as a 
result of detoxification reactions. Both chromatid-type and chromosome-type aberrations are 
predictive of cancer. Although the number of metaphase cells counted was inadequate for 
statistical analysis, Z. aethiopica should also be included in the carcinogenicity study.  
 
Pelargonium and A. oppositifolia could not be examined for clastogenicity in the chromosomal 













be investigated with other test methods. The studies of DNA content of peripheral blood 
lymphocytes treated with the A. oppositifolia and Pelargonium extracts confirmed the absence of 
the G2-M phase and a blockage in the Go/G1 phase of the cell cycle. The South African A. 
oppositifolia is known to contain traces of ouabain (which can be completely absent); in addition, 
the plant is non-mutagenic and inhibits mitosis as observed in the current study. Other researchers 
have found no in vivo activity in the water-soluble acolongifloriside K, therefore this plant extract is 












































APPENDIX A (Materials: Salmonella reverse mutation assay) 
 
1. 0.5mM Histidine/Biotin solution,  
D-Biotin        0.12215g 
L-Histidine        0.07758g 
Distilled water       to final volume of 1000ml 
 
2. Top Agar 
Bacto difco agar       1.5g 
Sodium chloride (NaCl)      1.25g 
Distilled water       250ml 
 
3. Oxoid nutrient broth 
Oxoid nutrient broth No. 2     1.25g 
Distilled water       50ml 
 
4. 0.1M NADP 
NADP-sodium salt , Sigma (C21H27N7O17P3Na)   0.7466g or 
NADP-disodium salt, Roche (C21H26N7O17P3N2)   0.7880g 
Cold sterile distilled water      10ml 
 
The solution was filter sterilised in a laminar flow cabinet with a 0.22µm syringe filter. Aliquots 
of 2ml and 0.4ml were dispensed into cryovials and stored at -20oC. 
 
5. 25X Vogel Bonner Medium E (VB salts), used in minimal agar 
Magnesium sulphate 7 hydrate, MgSO4.7H2O (BDH)  5g 
Citric acid monohydrate, C6H8O7.H2O (BDH)   50g 
Di-potassium hydrogen phosphate, anhydrous, HK204P  250g 
Ammonium sodium hydrogen orthophosphate  
NH4NaHPO4.4H2O      87.5g 
Warmed distilled water (45oC)     to final volume of 1000ml 
 
Dispense two 500ml aliquots into two 1L Schott bottles, and autoclave at 121oC for 20min.  
 
6. 40% Glucose solution 
D-(+)-glucose, BDH      400g 














Dissolve; divide into two 500ml aliquots using 1L Schott bottles and autoclave at 121oC for 
20min. 
 
7. Minimal glucose agar plates (MGA) 
Bacto Difco agar       15g 
25x VB salts       40ml 
40% glucose       50ml 
Distilled water       to 1L 
 
Autoclave at 121oC for 20min, cool slightly, add 40ml 25X VB salts and 50ml 40% glucose. 
Ensure that the solution is thoroughly stirred. Pour 30ml into each 90mm petri plate. Allow to 
set and store at 4oC. 
 
8. 1M Glucose-6-phosphate (used in the preparation of S9 mix) 
D-glucose-6-phosphate (disodium salt hydrate, anhydrous 
m.wt 304)        2.82g 
sterile distilled water      10ml 
 
The solution was filter sterilised with a 0.22µm syringe filter. Aliquots of 1ml and 2ml were 
dispensed into cryovials and transferred to storage at -4oC.  
 
9. 0.2M Sodium phosphate buffer pH7.4 
9.1) 0.2M sodium dihydrogen phosphate, NaH2PO4.H20  
(m.wt=137g/mol, BDH)      13.8g 
9.2) 0.2M disodium hydrogen orthophosphate, anhydrous 
Na2HPO4  (m.wt=142)      14.2g 
Distilled water       to final volume of 1000ml 
 
The two solutions were prepared separately and then combined as follows: 60ml of 9.1 and 
440ml of 9.2. The pH of the solution was adjusted to 7.4 by adding 9.1, transferred to a 1L 
Schott bottle and autoclaved at 121oC for 20min. Store the cooled solution in a refrigerator. 
 
10. 2-Acetamidofluorene (2-AAF) 
2-AAF        0.00506g 






















TA98 (1.5µg/0.1ml) TA100 (9µg/0.1ml) 
2-AAF stock 
(0.002g/ml) 
400µl 30µl 180µl 
DMSO 3.6ml 3.97ml 3.82ml 
Total volume 4ml 4ml 4ml 
 
11. Cumene hydroperoxide  
Cumene hydroperoxide (80% solution in cumene, Sigma) 100µl 
DMSO        to final volume of 50ml 
Reagent 
CHP working standards for dose response verification 





CHP stock 1.6mg/ml 0.13ml 0.31ml 0.5ml 0.69ml 0.88ml 
DMSO 0.87ml 0.69ml 0.5ml 0.31ml 0.12ml 
Total volume 1ml 1ml 1ml 1ml 1ml 
 
 
12. Salt solution (1.65M KCl + 0.4M MgCl2), used in S9 mix for mutagenicity assay 
Potassium chloride (KCl)      61.5g 
Magnesium chloride (MgCl2.6H2O)    40.7g 
Distilled water      to final volume of 500ml 
 
Autoclave at 121oC for 20min and store at 4oC. 
    
13. Preparation of S9 mix (standard S9 mix, 4%) 
Salt solution MgCl2.KCl      1ml 
1M Glucose-6-phosphate      0.25ml 
0.2M Phosphate buffer pH7.4     25ml 
Sterile distilled water      19.75ml 
0.1M NADP       2ml 
Rat liver S9       2ml 
 
Add the ingredients in the order indicated so that the rat liver S9 will be added to a buffered 
solution. Thaw a 2ml aliquot of S9 and keep on ice. Preparation is done in a laminar flow hood 
and all ingredients should be chilled, whilst the S9 mix is prepared on crushed ice. Any left over 















14. Nutrient broth agar plates (NBA) 
Oxoid nutrient broth No. 2                                                           25g 
Bacto difco agar       15g 
Distilled water       1000ml 
 
Autoclave at 121oC for 20min, dispense into 90mm petri plates, cool and store at 4oC. 
 
15. Crystal violet solution (0.1%, w/v) 
Crystal violet       100mg 
Distilled water       100ml 
 
Dissolve the crystal violet in the 100ml of water. Mix well and store at 4oC in a brown glass 
bottle to protect against light. 
 
16. Ampicillin solution (0.025% w/v) 
Ampicillin        2.5mg 
Distilled water       10ml 
Dissolve the ampicillin in warm (65oC) water. Filter sterilise using a 0.2µm filter and store at 
4oC. 
 
18. Ampicillin solution 0.8%, w/v 
Ampicillin        0.00295g 
Warm sterile distilled water     36.875ml 
 
Filter sterilise using a 0.2µm filter and store at 4oC. Minimal glucose agar (MGA) plates are 
supplemented with two drops of 0.8% w/v ampicillin solution by spread plating. 
 
17. Tetracycline solution (0.022% w/v) 
Tetracycline (Sigma)      0.0022g 
Hydrochloric acid (0.02N)      10ml 
 
Oxoid nutrient broth No. 2 (4850ul) was supplemented with 50ul 0.022% w/v tetracycline and 
100ul 0.025% w/v ampicillin solution 
 
18. Tetracycline solution (0.8%, w/v) 
Tetracycline       0.00140g 













Dissolve the tetracycline in the 0.02N HCl, filter sterilise with a 0.2µm syringe filter into a sterile 
bottle, wrap with foil and store at 4oC (tetracycline is light sensitive). 
 
19. Biotin solution (0.01%, w/v) 
D-biotin        10mg 
Distilled water       100ml 
 
Filter sterilise using a 0.45µm filter and store at 4oC. 
 
20. Histidine solution (0.5% w/v) 
L-Histidine        500mg 
Distilled water       100ml 
 





































APPENDIX B (Materials: Flow activated cell sorting) 
1. Rnase Working solution (10µg/ml) 
A dilution (1:100) of Rnase was made by adding 40µl Rnase stock (10mg/ml) to 3.96ml 1x 
PBS. Ensure that there is sufficient Rnase working solution for the number of samples to be 
analysed. Aliquots of 0.1ml Rnase working solution is added to the pellet. 
 
2. Phosphate Buffered Saline (10x stock) 
Sodium chloride (NaCl)      80g 
Potassium chloride (KCl)      2g 
Na2HPO4.7H2O       11.5g 
KH2PO4        2g  
Add water to 1000ml 
 
3. Staining solution 
An aliquot of 1ml staining solution per sample is required. Forty millilitre of staining solution is 
made as follows: 
Stock Stock concentration Volume for 40ml 
Triton X-100 100% 40µl 
MgCl2 1M 80µl 
NaCl 5M 0.8ml 
PIPES 0.1M 4ml 
PI (propidium iodide) 1mg/ml 0.4ml 
Total  5.32ml 
H2O  34.68ml 
 
4. 0.4% Trypan Blue stain (for viability) 
0.4% trypan blue was prepared in 1x PBS 
 
5. Cell lysis buffer 
NH4Cl        8.34g 
EDTA        0.037g 
NaHCO3        1.00g 
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